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Abstract 
The musculoskeletal system is crucial for vertebrate organisms which rely on movement. During 
development, the musculoskeletal system arises from clusters of transient mesoderm termed somites. 
Somites contain the cellular precursors of skeletal muscle, tendons, cartilage, some bone, and the 
dermis. The proliferation, specification, and differentiation of the different musculoskeletal cell lineages 
is controlled by gene regulatory networks, where changes in gene expression patterns reflects the 
differentiation of somitic cellular lineages.  The changes in the transcriptome of somites undergoing 
differentiation can also be linked to the dynamic changes in chromatin accessibility. Accessible regions 
of chromatin can be identified using ATAC (Assay for Transposase Accessible Chromatin), and many 
accessible regions have been found scattered throughout the epigenome. These regions have been linked 
to epigenetic regulatory mechanisms, including the cis-regulatory elements known as enhancers. By 
utilising both ATAC-sequencing and RNA-sequencing datasets previously generated in the 
Münsterberg lab, this project aimed to identify novel enhancers involved with somite cellular lineage 
differentiation that govern the gene regulatory networks in differentiating somites. The RNA dataset 
was conducted on somites removed from stage fourteen chicken embryos, which helped to identify 
genes involved in the differentiation of musculoskeletal lineages. Genes identified as having differential 
activity in the more differentiated somites compared to the pre-somitic mesoderm included ALX1, 
UNCX, KLHL31, MEOX2, FOXO1, SCX, MKX, TNC PAX1 and PAX9 genes. The ATAC-
sequencing dataset was utilised to find regions of open chromatin near these genes of interest, which 
may indicate a putative enhancer region. Twenty-nine different putative enhancer regions were 
identified by analysis of the ATAC-sequencing dataset. To determine the spatio-temporal activity of 
these putative enhancer regions, they were cloned into fluorescent reported constructs, which were 
injected and electroporated into stage three chick embryos. Of the ten enhancer constructs tested, one 
enhancer associated with the Foxo1 gene showed fluorescent reporter activity in blood islands and 
sporadically throughout the inter-somitic blood vessels and the dorsal aorta. Genes identified from the 
RNA sequencing that had yet to be characterised in the chicken embryo were visualised spatially 
throughout development using whole mount in-situ hybridisation techniques, generating gene 
expression profiles.  An expression profile for the fork-head protein Foxo-1 was generated using in-situ 
hybridisation and cryosectioning techniques, along with the identification of the Scleraxis gene in 
younger embryos than previously reported. Overall, this project was able to use ATAC-sequencing to 
identify one cis-regulatory element associated with the Foxo-1 gene and generate a corresponding 
expression profile.  
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Chapter 1: Introduction 
 The musculoskeletal system is important for many vertebrate functions, including locomotion, 
respiration, feeding, postural support and communication. Proper formation of the musculoskeletal 
system relies on the coordinated development of tendons, cartilage, bone, and muscle, the majority of 
which arise from the somites (Kalcheim and Ben-Yair, 2005). It is crucial that we properly understand 
the genetic regulation involved in muscle, tendon, and cartilage development, as improper development 
of these tissues can result in several muscular disorders, complicating post-natal life.  
 
1.1 Gastrulation  
  The somites arise from the mesodermal germ layer, which is specified during the gastrulation process. 
During vertebrate gastrulation, cells in the epiblast start to ingress to the interior of the embryo and form 
the primitive streak, which is first visible as a thickening of the epiblast. As these cells enter the 
primitive streak, it elongates towards the head end, and defines the posterior-anterior axis of the embryo. 
Cells migrate through the primitive streak, which results in the formation of the three germ layers: the 
mesoderm, the endoderm, and the ectoderm (Vasiev et al., 2010), see figure 1.1. The endoderm layer 
is formed by epiblast cells that migrate through the primitive pit and displace the hypoblast cells; cells 
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of the endoderm give rise to epithelial linings, the liver and pancreas. The mesoderm layer lies between 
the epiblast layer and the newly formed endoderm, and ingress at the primitive streak. Cells from a 
mesodermal lineage will give rise to the notochord, the musculoskeletal system, and the circulatory 
system. The ectodermal layer does not invaginate and become parts of the nervous system and the 
epidermis of the skin (Kiecker et al., 2015). 
 
 
Figure 1.1: Diagram displaying vertebrate gastrulation. During this process, cells of the epiblast undergo an epithelial to 
mesenchymal transition (EMT) and ingresses at the primitive streak. The migrating cells form the mesodermal and endodermal 
layers, while those that maintain their epithelial state form the ectoderm layer. Figure from Wolpert et al., 2015.   
 
1.2 Somite Development 
 Somites arise from the mesodermal compartment and are a common feature in the phylotypic stage of 
all Chordata. The somites are transient structures which form bilaterally on either side of the notochord, 
and give rise to multiple crucial body structures, including the skeletal muscle, tendons, bone, dermis 
and cartilage. Somites form from the paraxial mesoderm, an area of mesoderm that flanks the neural 
tube. The formation of somites (somitogenesis) involves the sequential segmentation of the paraxial 
mesoderm to form pairs of somites. In chick, one pair of somites forms about every 90 minutes, with a 
total of 52 somite pairs forming.  
 
 It has been demonstrated that the pre-somitic mesoderm (PSM) is specified within the primitive streak 
of the chicken and mouse embryo (Cambray and Wilson, 2007). Lineage analysis of somites in chicken 
embryos demonstrated that the progenitors that give rise to the medial half of the somite are found in 
the Hensen’s node, an enlarged group of cells located in the anterior portion of the primitive streak, 
whereas progenitors that give rise to the lateral half of the somite are derived from cells found posterior 
to the node in the primitive streak (Selleck and Stern, 1991). These progenitors then migrate out of the 
streak, into the PSM, and are characterised by the expression of Tbx6 (White, 2003). PSM continues to 
leave the streak as somites are formed, so there is a continual supply of pre somitic mesoderm at the 
caudal end of the embryo until the tail bud forms, where ingression stops (Dequéant and Pourquié, 
2008).   
 
  The precise timing of somite segmentation is driven by the clock and wavefront mechanism. The first 
evidence for this model was the periodic expression of the transcription factor C-HAIRY1 in the PSM 
(Pourquié, 2011), which suggested an oscillator associated with segmentation. The Notch target Lunatic 
fringe was then identified as another cyclic gene oscillating with HAIRY (Evrard et al., 1998). The 
segmentation clock drives the expression of the ‘clock’ genes, which cause the cells of the PSM to 
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undergo a mesenchymal to epithelial transition (MET). This results in the most anterior portion of the 
PSM budding off, generating an epithelial somite (Stern and Piatkowska, 2015). Other clock genes that 
play a role in this segmentation process include components of the wnt, FGF and notch signalling 
pathways. The Notch pathway is negatively regulated through Lunatic Fringe (Dale et al., 2003, 
Dequéant and Pourquié, 2008), and has shown to be crucial for clock gene oscillations and somite 
formation (Ferjentsik et al., 2009).  
 
  The determination front is an area in which the PSM can begin segmentation. This area is defined by 
a posterior-anterior gradient of Fgf8 and nuclear β-catenin expression with an anterior-posterior 
gradient of retinoic acid (Moreno and Kintner, 2004). Fgf8 is expressed at high levels in the posterior 
PSM, maintaining an undifferentiated state in these cells. When the FGF pathway is activated by MEK, 
the expression of RA-synthesising enzyme raldh is inhibited, preventing the synthesis of RA. Thus, the 
gradient of FGF and RA is determined, with FGF negatively regulating RA synthesis (Vermot and 
Pourquié, 2005). Figure 1.2 below shows this molecular determination front between Fgf8 and RA.  
 
 
Figure 1.2: A simple diagram showing the posterior to anterior gradient of FGF establishing the determination front. Only 
when FGF drops beneath a certain threshold value will cells undergo MET to form somites. This threshold defines the 
determination front, marked by expression of lunatic fringe in chick, and mesp2 in mouse (as shown by the black lines). 
Adapted from Pownall and Isaacs, 2010. 
 
  Somites form once lunatic fringe is free from inhibition by FGF and notch signalling is activated, 
triggering a genetic cascade. Lunatic fringe expression is restricted to the anterior half of the prospective 
somite. This is one example of rostro-caudal patterning in somites, which is consistent with the re-
segmentation theory. The re-segmentation theory arose from an observation that vertebrae form from 
the fusion of the rostral part of one somite, and the caudal end of another (Brand-Saberi and Christ, 
2000). Several other genes, such as UNCX4.1, TBX18 and C-hairy1 can be found in either the rostral 
or caudal half of the prospective somite (Tanaka and Tickle, 2004). The anterior-posterior separation 
happens later in somite differentiation, in a region termed the fissure of Von Ebner, which is found in 
the sclerotome. While both the sclerotomal halves will give rise to the vertebral body, the caudal half 
will form the vertebral pedicle, while the rostral half will give rise to the intervertebral disks (Goldstein 
and Kalchiem, 1992).  Figure 1.3 below demonstrates how re-segmentation leads to the formation of 
the mature vertebrae segments.  
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Figure 1.3: The anterior-posterior patterning of somites in the sclerotome, and how these interact to form vertebrae. A) The 
posterior part of the sclerotome is marked by Uncx4.1, while the anterior portion is marked by expression of TBX18 (B). C) A 
simple diagram showing re-segmentation of somites. Each vertebra is formed via the fusion of the posterior half of one somite 
and the anterior half of another (Baldock, 2016) regions depicted are: 1) vertebrae 2) the pedicle 3) Inferior vertebral notch 
4) intervertebral discs. 
 
1.2.1 Somite Differentiation and Early Patterning 
 
Once the somite buds of from the PSM, it becomes an epithelial somite. Epithelial somites have an 
epithelial wall surrounding the central cavity, called the somitocoel, which contains loose mesenchyme 
(Scaal and Christ, 2004). This epithelial somite then begins to mature as it is exposed to inductive 
signals from surrounding tissues that pattern the somite (Aoyama and Asamoto, 1998). Several key 
changes occur after exposure to inductive signals; the ventral part of the somite undergoes EMT and 
forms a ventral mesenchyme, called the sclerotome, while the dorsal part of the somite remains 
epithelial and is termed the dermomyotome (Scaal and Christ, 2004). The dermomyotome also separates 
into the myotome and the dermatome, which give rise to separate tissues. As the somite continues to 
mature, interactions between the myotome and the underlying sclerotome give rise to a third somitic 
compartment, the syndetome, and the somite then described as a fully differentiated somite (see figure 
1.4).  These signalling pathways act to produce and differentiate somites from PSM from stage 7 to 
stage 25, where somitogenesis is terminated (Tenin et al., 2010).  
 
Figure 1.4: A schematic diagram showing the progressive differentiation of somites. The most posterior region is the 
presomitic mesoderm (PSM), which generates a new pair of epithelial somites. The somite then begins to mature, with ventral 
regions undergoing an EMT to give rise to two different compartments of the somite, the dermomyotome and the sclerotome. 
The most differentiated somite is the most anterior one, containing the sclerotome, syndetome, myotome and dermomyotome. 
These different regions give rise to different cell lineages (Adapted from Buckingham et al.,2003).   
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  There are several genetic signals that trigger the formation of the sclerotome and the dermomyotome. 
Sonic hedgehog (Shh) and noggin signals from the floor plate and the notochord promote de-
epithelialisation and a mesenchymal fate, forming the sclerotome in the ventral part of the somite 
(Borycki et al., 1998). Exposure to Shh induces Pax1 and Pax9 expression in the sclerotomal cells, 
which then triggers a genetic programme for further specification (Yusuf and Brand-Saberi, 2006) (see 
section 1.2.4). The sclerotome cells migrate to near the notochord and later produce the vertebrae and 
the ribs (Scaal and Christ, 2004). Shh signals from the notochord are also sufficient and necessary to 
activate MyoD gene expression in the myotomal region, beginning the muscular differentiation pathway 
(Borycki et al., 1998). Canonical Wnts such as Wnt4, Wnt6 and Wnt8c signalling from the overlying 
ectoderm have been recognised as major dorsal signalling factors in the establishment of the epithelial 
dermomyotome. They maintain the epithelial organisation of the dorsal part of the somite, inducting 
expression of Pax3 and Pax7, forming the dermomyotome (Münsterberg et al., 1995, Yusuf and Brand-
Saberi, 2006).  
 
  The dorsal Wnt signals and the ventral Shh work synergistically to develop the myotome, and begins 
the muscular differentiation pathway (Borycki et al., 1998).  Cells from the medial and lateral parts of 
the dermomyotome begin to express the myogenic factors Myf5 and MyoD, giving rise to the underlying 
myotome, which goes onto produce the epaxial and hypaxial muscles. Canonical Wnt signalling can 
directly induce genes such as Paraxis, which maintains the epithelial organisation of the dorsal somite 
(Linker et al., 2005).  Shh signals from the notochord with Wnt signalling regulate MyoD gene 
expression through Gli2 and Gli3 in the myotomal region (Borycki et al 2000). As the formation of the 
myotome requires both dorsal and ventral signals, it has been suggested that Shh and Wnt family 
members act through a concentration gradient that is established along the dorsoventral axis. This 
gradient is also maintained by the presence of competitive Wnt and Shh inhibitors, present in the 
prospective sclerotome and dermomyotome respectively. For example, the secreted frizzled-related 
protein 2 (Sfrp2) is a Wnt antagonist upregulated by Shh. It is expressed in the sclerotome, induced by 
Shh, and prevents the dorsalising effect of Wnt signalling (Lee et al., 2000). Only one candidate Shh 
antagonist has been discovered, the Growth-arrest specific gene1 (Gas1), which is inducible by Wnt 
proteins, (Lee et al., 2001). Once the myotome has separated from the dermomyotome, Neurotrophin 3 
(NTF3) expression maintains the dermatome, which gives rise to dermis tissue (Brill et al., 1995). Wnt, 
Shh and BMP signals patterning the early somite is shown below in figure 1.5.  
 
  Bone morphogenetic proteins, (BMPs) are another key family of proteins that work to pattern the 
somite. They play a variety of differing roles in the patterning of the somite. BMP4 is expressed in the 
dorsal neural tube where it indirectly induces the expression of Wnt11 in the dorsomedial lip of the 
dermomyotome (Marcelle et al., 1997). This is the region that then forms the myotome and begins to 
express MyoD. However, other work suggests that BMP4 negatively regulates myogenesis, by 
preventing expression of MyoD and Myf5 (Reshef et al., 1998, Pourquie et al., 1996). Noggin 
antagonises BMP proteins by preventing them from binding their receptors (Zimmerman et al., 1996), 
and is therefore present in the medial somite. This work suggests a dual role for BMP-4, depending on 
where its expression is present. When present in the dorsal neural tube, it indirectly induces expression 
of wnt-11 in the dermomyotome. However, when BMP4 is expressed in the lateral plate mesoderm, it 
induces the differentiation of dermomyotome cell into Met expressing cells and represses myogenic 
differentiation.  The action of BMP signalling on somite patterning is shown below in figure 1.5 and 
1.6.  
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Figure 1.5: A simplistic schematic depicting a section through the somite and neural tube demonstrating some of the signalling 
pathways involved in the early formation of the somite. Canonical wnts from the dorsal neural tube and surface ectoderm 
induce the dermomyotome. Shh signals from the neural tube floor plate and notochord along with BMP4 signals from the 




Figure 1.6: A model of BMP patterning of the dermomyotome. BMP regulates Wnt1 expression in the dorsal neural tube, 
which then induces expression of wnt11 in the medial lip. BMP is antagonised and therefore prevented from signalling by 
Noggin in the medial somite. Wnt-11 expression allows the present muscle progenitors to become the myotome (blue arrow). 
Shh represses Wnt-11, maintaining the dorsal expression of wnt-11. Figure from Marcelle et al., 1997.  
 
1.2.2 Myogenesis  
  Muscle forms from the myotome compartment within somites, and myogenesis is mainly regulated by 
four key Myogenic Regulatory Factors, Myf5, MyoD, MyoG, and Mrf4 (Scaal and Christ, 2004). MyoD 
and Myf5 are muscle specific transcription factors that lie at the top of the transcriptional regulatory 
network, with disruption of this network resulting in complete failure of skeletal muscle formation 
(Rudnicki et al.,1993). Myogenin (MyoG) acts during terminal differentiation of committed myoblasts 
(Berkes and Tapscott, 2005). Mrf4 is expressed both in postmitotic maturing cells and undifferentiated 
proliferating cells, acting as both a determination gene and a differentiation gene (Kassar-Duchossoy et 
al., 2004). Most types of skeletal muscles express a subset of these four genes during development, but 
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different muscle differentiation pathways require different upstream and downstream signals (see figure 
1.7).   
 
 
Figure 1.7: A diagram depicting the different genetic pathways for muscle development in differing muscle types. Image from 
Braun and Gautel, 2011. All skeletal muscle cells express a sub- set of these myogenic regulatory factors (Myf5, MyoD, MyoG 
and Mrf4). 
 
  The Wnt, Shh and BMP signalling pathways all play a role in myogenesis. Mouse knockout mutants 
for wnt1 lacked parts of the dermomyotome, and the expression of the early sclerotome transcription 
factors pax1 and Pax9 (Ikeya and Takada, 1998). It has been shown that different wnt proteins act to 
induce expression of different myogenic regulatory factors; Wnt1 increases Myf5 expression levels, yet 
Wnt7a or Wnt6 induced expression of MyoD (Tajbakhsh et al., 1998). This has been linked with the wnt 
receptors frizzled, and the canonical and non-canonical wnt signalling pathways.  Fzd7 is expressed in 
the hypaxial portion of the somite, where it binds wnt7a and signals through the non-canonical 
pathway.  Fzd1 and Fzd6 are expressed in the epaxial region of the somite, where they are bound by 
Wnt1 and signal through β-catenin dependent pathway (Borello, 2006). Sonic Hedgehog also plays a 
role in for specification of muscle progenitors. Shh or their receptor Smoothened knockout mice display 
a reduction of Myf5 in the myotome, and improper formation of the sclerotome (Zhang et al., 2001). 
Chicken gain of function assays showed that ectopic expression of Shh increases the levels of the 
sclerotomal marker Pax1 and inhibited expression of Pax3 in the dermomyotome, a step that is crucial 
for commitment of myotomal cells (Borycki et al.,1998). BMP signalling negatively regulates 
myogenesis, by inducing expression of Pax3 which inhibits Myf5 and MyoD induction (Pourquie et al., 
1995).  
 
  The paired box transcription factors Pax3/7 are both induced by BMP, Wnt and Shh signalling. In 
mouse epaxial muscles, Pax3 activates Myf5 through the expression of Dmrt2, which in turn binds to 
the Myf5 enhancer region (Sato et al., 2010). Ectopic expression of Pax3 in the paraxial mesoderm 
showed it can induce MyoD, MyoG and Myf5 in the absence of inducing tissues (Maroto et al., 1997). 
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Pax7 is a homologue of Pax3, with each gene being able to compensate for the other in knock down 
experiments (Relaix, 2004), but in experiments with a double knockout, these mutants displayed a 
severe disruption of muscle development, with few differentiated cells (Relaix et al., 2005).  Pax3 
regulates key components of the FGF signalling pathway, that was shown to be involved in the 
expansion of the myogenic progenitor cell pool (Lagha et al., 2008). All these findings suggest that 
Pax3 and Pax7 are responsible for increasing the size of the muscle precursor cell populations, making 
them likely to differentiate towards a myogenic fate. In hypaxial muscles, it has been shown that Pax3 
directly induces expression of Myf5. Regulation of Myf5 comes from a 145bp regulatory element 57.5kb 
upstream of the Myf5 locus. This regulatory region contains a Pax3 binding site, and mutation of this 
site leads loss of Myf5 expression in mouse embryos (Bajard, 2006).  
 
  Sine oculis-related homeobox (Six) proteins also play a role in the early stage of myogenesis. SIX1 
and SIX4 also regulate the transcription of Myf5 by binding to the same regulatory element (Giordani 
et al., 2007). SIX1 mouse mutants die at birth, showing muscle hypoplasia in several key muscles, 
including the limbs (Laclef, 2003). In mice lacking both SIX1 and SIX4, there are no muscle progenitor 
cells in the limb buds, and no muscle forms (Grifone, 2005). Furthermore, these mice show no 
expression of Pax3 in the dermomyotome, suggesting that SIX proteins lie upstream of Pax proteins 
(Grifone, 2005). These mutants also display a reduced expression of MyoD and MyoG. Six proteins are 
clearly important for the early induction of myogenic cells.  
 
  Another group of proteins that promote myogenesis from the pool of undifferentiated cells are the 
myotome enhancer factors (MEFs). One of the better known MEF families, MEF2 proteins are 
transcriptional activators, regulated by the MAP kinase signalling pathway (Potthoff and Olson, 2007). 
MEF2 was first identified as a muscle gene expression regulator (Gossett et al., 1989), and has mostly 
been studied in Drosophila. It is expressed in early mesoderm, and throughout different muscle 
lineages, with a main role in myoblast differentiation.  Several enhancers control the expression of 
Mef2; expression in the early mesoderm requires an enhancer that is activated by twist (Cripps et al., 
1998), whereas the proteins MAD and Meda act on a separate enhancer to control its expression in 
somites (Nguyen and Xu, 1998). Mef2 can also auto regulate itself in the late muscle differentiation 
stage, by activating a distal autoregulatory enhancer (Cripps et al., 2004). In Drosophila embryos where 
Mef2 is mutated, there is a complete block in myoblast fusion and expression of muscle differentiation 
markers (Ranganayakulu et al., 1995). This set of proteins are critical in the differentiation of muscle 
and lineage specification.    
  
  Micro-RNAs (miRNAs) also play a key role throughout the differentiation of the myotome. Micro-
RNAs are transcribed from small non-coding regions of DNA and regulate gene expression post-
transcriptionally. Many miRNAs are expressed specifically within muscle tissue, and are involved in 
myogenesis (Boutz et al., 2007).  Chromatin immunoprecipitation followed by microarray (ChIP-chip) 
analysis showed that MyoG and MyoD bind upstream of miR-1 and miR-133 (Rao et al., 2007). Myf5 
is specifically required for miR-1 and miR-206 expression, which was absent in the somites of Myf5 
mutant mice (Sweetman et al., 2008). miRNAs tend to be involved in myogenic differentiation and are 
up regulated after differentiation (Mok et al., 2017). It has been suggested that miR-1 accelerates 
myoblast differentiation by downregulating expression of histone deacetylase 4, a known repressor of 
muscle differentiation, and knockdown of miR-1 slows myogenic differentiation (Chen et al., 2005). 
Various other miRNAs have been shown to be a crucial aspect of myoblast differentiation, overall 
adding to the complexity of the muscle development pathway.    
 
  There are many key steps in muscle differentiation in the embryo. It is worth studying and 
understanding these processes, as not only is it important from a developmental point of view, but also 
for postnatal human muscle disorders and injuries, as a similar genetic programme that is deployed in 
developing embryos is also used in adults when repairing broken muscle fibres. Mutations in genes that 
are involved in muscle development can be identified in embryos. Once gene regulatory network that 
the mutation disrupts is known, which can again be identified by experimentation in embryos, work can 
begin on finding therapies for individuals who suffer from a muscle disease phenotype.   
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1.2.3 Chondrogenesis  
  Chondrogenesis is the process that leads to the formation of chondrocytes, which in turn give rise to 
cartilage and produce proteoglycans of the extra-cellular matrix. These cells arise from the sclerotomal 
region within somites, which are marked by the expression of several genes, including Pax1, Pax9 and 
Nkx3.1 (Monsoro-Burq, 2005). Sclerotomal cells give rise to many different anatomical structures, 
including the axial skeleton, ribs, and vertebrae as well as cartilage (Christ, et al., 2004). The ventral 
sclerotome is the origin of vertebral bodies and intervertebral discs (Christ, et al., 2004). Populations 
of cells from the dorsolateral sclerotome migrate to and engulf the neural tube, giving rise to 
chondrocytes and eventually cartilage (Brent et al., 2004). The ribs and vertebrae are formed by a 
process called endochondral ossification, where the growing cartilage forms a scaffold which is then 
replaced by bone to form the growing skeleton (Ortega et al., 2004).    
 
  The genetic programme that controls the differentiation of the sclerotome is complex. Initially, Shh 
signalling from the floor plate, along with BMP and noggin signalling defines the sclerotomal section 
of the somite (Monsoro-Burq, 2005), marked by expression of Nkx3.2 (Rainbow et al., 2014). Shh also 
drives the expression of Pax1 and Pax9, two key sclerotomal markers (Cairns, 2008). In Pax1/Pax9 
double mutant mice, the ventral parts of the vertebra are severely deformed, with the mutants completely 
lacking the vertebral bodies, intervertebral discs and the proximal part of ribs (Peters et al., 1999). 
Although Pax1 is critical for the formation and maintenance of the sclerotome, Pax1 inhibits further 
differentiation into chondrocytes (Takimoto et al., 2013), and is downregulated during chondrogenic 
differentiation.  
 
   Pax1 and Pax9 act upstream of Nkx3.2 at the start of sclerotomal formation and activate the expression 
of chondroblast markers (Rodrigo, 2003). Nkx3.2 represses the myogenic marker Pax3 which is 
expressed in the dermomyotome, maintaining the mesenchymal state of the sclerotome, also blocking 
transcription of Sox9 repressors (Zeng, 2002). In Nkx3.2 mutants, the sclerotome forms, induced by 
Pax9, but does not further differentiate, demonstrating the key role for this gene (Rainbow et al., 2014). 
However, whilst Nkx3.2 is critical for chondrocyte cell fate specification and proliferation, it is a 
negative regulator of chondrocyte maturation, and Nkx3.2 misexpression results in delayed chondrocyte 
maturation, by repressing Runx2 (Provot, 2006). In humans, a recessive mutation of Nkx3.2 results in 
spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD). SMMD is a rare autosomal recessive 
skeletal dysplasia, with a phenotype of short stature, with a short and stiff neck and impaired ossification 
of the vertebral bodies (Simon et al., 2012).  In the mouse, knockouts of Nkx3.2 results in embryonic 
lethality in mice, preventing further study.    
 
 One of the markers induced by Nkx3.2 and Pax1/9 is Sox9, a pivotal transcription factor expressed 
throughout developing and adult cartilage.  Its importance was highlighted when it was discovered that 
mutations in Sox9 lead to the human early lethal syndrome known as Campomelic Dysplasia (Lefebvre 
and Dvir-Ginzberg, 2016). Sox9 binds to enhancers that activate various cartilage genes, increasing 
expression (Lefebvre and Dvir-Ginzberg, 2016). Genes such as COL2A1 and Tenascin-C are then 
upregulated by Sox9, leading to cartilage formation.      
  
1.2.4 Tendon development  
  As the somite matures, the tendon lineage is established within the dorsal sclerotome, in an area termed 
the syndetome (Brent et al., 2003). The syndetome arises at the same time as the myotome emerges 
from the dermomyotome. The basic helix-loop-helix (bHLH) gene Scleraxis is the main genetic marker 
of early syndetome (Cserjesi et al., 1995), and is induced by Fgf4 signals from the central myotome.  
The Fgf4 proteins bind to their receptor FREK, which has a restricted expression pattern to the cranial 
and caudal borders of the myotome (Edom-Vovard et al., 2002).   
 
  Previous studies have also indicated that the transforming growth factor-β (TGFβ) is required for the 
early signalling pathways for tendon development and throughout tendon development (Tan et al., 
2020). TGFβ, is a potent inducer of Scx, and disruption of TGFβ signalling resulted in a complete failure 
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of tendon development (Pryce et al., 2009). Overexpression experiments with the members of the TGFβ 
superfamily resulted in ectopic new tendon formation in rats (Wolfman et al., 1997), suggesting that 
TGFβ proteins are crucial for the development and formation of tendons.   
 
1.3 Genetic Loci and Chromatin Structure 
  To enable gene expression, the transcription start site (TSS) of a gene must be accessible. The length 
of DNA in the nucleus is far greater than the size of the nucleus in which it is stored, and for DNA to 
fit into the nuclear compartment, it is packaged down 10,000-20,000-fold into chromosomes. 
Chromosomes form pairs, and there are varying numbers of chromosomes present in different species; 
for example, there are 23 pairs of chromosomes in human, 20 pairs in mouse and 39 pairs in chicken. 
Chromosomes are tightly packaged to contain the vast amount of genetic material. In eukaryotes, 
chromosomes are composed of chromatin fibre, which contains nucleosomes. A nucleosome consists 
of 147 base pairs of DNA that is wrapped around a set of eight histones, termed an octamer, which are 
further described below. Chromatin fibres are further condensed by proteins into a structure called 
chromatin, which is present in most cells that contain a nucleus. The folding of the chromatin fibre in 
the cell nucleus is tightly linked to biological function and gene expression and characterizing the 
conformational and dynamical properties of chromosomes has become crucial to further understanding 
how genes are regulated. The packaging of DNA is described below in figure 1.8.  
 
 
Figure 1.8: The packaging of DNA into a chromosome. The DNA double helix is wrapped around histone octamers, 
resulting in closed chromatin, and is described as a nucleosome These nucleosomes are further packaged into the chromatin 
fibre, roughly 30nm in width, which is all packaged into the chromosome. (Fyodorov et al., 2017).  
 
  Histones are a family of proteins that associate with DNA in the nucleus and help it to condense into 
chromatin. Five major families of histones exist: H2A, H2B, H3 and H4, which make up the core histone 
and H1/H5 which are known as linker histones. The core histones exist as dimers, which then come 
together as two H2A-H2B dimers and a H3-H4 tetramer to form one octameric nucleosome core. The 
linker histone H1 binds the nucleosome at entry and exit sites of the DNA, locking it into place, and it 
Page | 15  
 
is here where most epigenetic modifications occur, to release the DNA from the nucleosome, and grant 
the transcription machinery access (this is talked about in more detail in 1.4.3).   
 
  Genes are transcribed from their genetic loci, the physical region of a gene on a chromosome. It is 
important we understand how transcription works to elucidate the mechanisms by which it is controlled. 
In its most basic form, the transcription machinery first finds an accessible promoter and assembles a 
protein complex, which recruits RNA-polymerase II (Kornber et al., 2007).  DNA helicase is also 
recruited and unwinds double stranded DNA so that RNA polymerase II can use single stranded DNA 
as template. This produces a single stranded messenger RNA molecule (mRNA), which is then 
translated by the ribosomes, to produce a string of amino acids. Genetic loci contain introns (non-coding 
regions of DNA) and exons (coding regions of DNA). Introns are removed by RNA splicing post 
transcriptionally, meaning they are not present in the final mature mRNA.  
 
  Genetic loci are further organised in the genome into topologically associated domains (TADs). TADs 
are fundamental units of three-dimensional nuclear organisation, which restricts the activity of other 
genetic loci from acting upon its own (Dixon, Gorkin and Ren, 2016). They are hundreds of kilobases 
to several million bases in length and are evolutionarily conserved (Dixon et al., 2012). They are 
important for two reasons; they have a self-association property, as cis-regulatory regions and genetic 
loci can only act upon other genetic loci within their TAD, and an insulating property from neighbouring 
TADS. Previous studies on various diverse cell types indicated that TADs are fairly invariant, as 
opposed to other chromosomal features (Dixon et al., 2012), meaning they are more likely to be 
involved with chromosome organisation rather than specific gene activation. When TADs are disrupted, 
disease can occur as other cis-regulatory elements act outside their restricted domain (Lupiáñez et al., 
2015, Hnisz et al., 2016), and multiple regulatory elements have been shown to affect the activity of 
multiple loci within a TAD (Symmons et al., 2014). One implication for this is that distal regulatory 
interactions have the potential to be non-specific within a TAD domain. It is important to acknowledge 
the importance of TAD domains and chromatin structure during the search for cis-regulatory elements.    
 
1.4 Epigenetic control 
   Epigenetics, first defined by Waddington in 1942, was used to describe the changes in phenotype 
without changes to the genotype (Waddington.,1942). In the following years, the concept of epigenetics 
helped explain phenomena such as X inactivation and imprinting. After a multitude of studies produced 
in the late 1900s, we now understand epigenetics as a mechanism to regulate genetic expression of key 
genes within the genome, which can be heritable both trans-generationally and by daughter cells. There 
are several different epigenetic mechanisms by which gene expression is regulated, which are key to 
the development of cell lineages. These individual mechanisms include DNA methylation, non-coding 
RNAs and histone modifications.  
1.4.1 DNA Methylation 
  The role of DNA methylation in regulating gene expression was proposed during the 1970s (Holliday 
and Pugh., 1975). The principal epigenetic tag found throughout differentiated mammalian cells is the 
covalent attachment of a methyl group to the C5 position of cytosine rings (Bird., 1986). Methylation 
tends to occur in CpG sites, where a cytosine residue is followed by a guanine nucleotide. The cytosine 
in CpG dinucleotides is methylated to form 5-methyl cytosines (Bird., 1986). In mammals, seventy to 
eighty percent of CpG sites are methylated (Jabbari and Bernardi., 2004), indicating methylation plays 
an important role in regulation of genetic expression.    
 
  Methylation of the cytosine residues is often associated with transcriptional repression (Weber et al., 
2007), especially if these methylated sites are promoters or other regulatory regions. It is thought that 
DNA methylation can suppress transcription through several mechanisms. Firstly, several studies have 
demonstrated that methylation can directly block binding of transcription factors (Aoyama et al., 2004), 
or recruit other factors, such as MeCP2, which binds to methyl CpG. MeCP2 then recruits other 
transcriptional repressors, such as histone deacetylases (HDAC), which promotes chromatin 
condensation, preventing transcription of genes (Nan et al., 1998). DNA methylation is regulated by 
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the enzymes DNA methyltransferases (DNMTs), which add methyl groups, and allows DNA 
methylation to remain stable and thus be passed from cell to cell, and trans-generationally (Chen et al., 
2003). Methylation is also regulated by TET enzymes, which lead to the removal of a methyl group by 
successive oxidation.      
 
  During embryonic development, methylation patterns follow two distinct rounds of epigenetic 
reprogramming (Zeng and Chen, 2019). The first wave of methylation reprogramming occurs during 
gametogenesis in the primordial germ cells, where nearly all methylation marks are removed from the 
genome (Zeng and Chen, 2019). At later stages of germ cell development, an increase in de-novo 
methylation results in the establishment of sex-specific germ cell methylation patterns, including 
methylation marks at imprinted loci. After fertilisation, there is an erasure of DNA methylation, but 
methylation marks are retained at imprinting control regions. In the implantation stage, another wave 
of methylation reprogramming occurs. Methylation appears at sites near to genes involved with general 
developmental processes, and a reduction in methylation near to genes with tissue specific functions 
(Weber et al., 2007). Recent studies looking at DNA methylation in promoter regions of DNA suggests 
that only a few CpG sites within the promoter regions are methylated, inhibiting only a small set of 
genes (Weber et al., 2007).  Many of these transcriptionally repressed genes are germline specific, 
suggesting that methylation plays an important role in the suppression of key genes during 
development.   
 
1.4.2 Non-Coding RNAs 
  A non-coding RNA (ncRNA) is a functional RNA molecule that is transcribed from regions within 
the epigenome but is not translated into a functioning protein (Cech and Steitz, 2014). They are 
abundant, regulating a broad spectrum of cellular processes. There are several different classes of 
known ncRNAs, including snoRNAs, scaRNAs, siRNAs snRNAs, lncRNAs and miRNAs, and are 
highly conserved throughout all forms of life (Cech and Steitz, 2014). ncRNAs are involved in RNA 
splicing, where they are components of the spliceosome (Kishore, 2006). They also work as a post 
translational control mechanism through gene silencing or transcribing (Rinn and Chang, 2012), or as 
a hormone (Knol, et al., 2015).  However, one of the main roles of ncRNAs is that they act as key 
regulators of chromatin structure in eukaryotes. Small RNAs can target gene expression through RNA 
interference (RNAi) pathways, which mediate histone or methylation events that can prevent 
transcription (Rinn and Chang, 2012). NcRNAs play a huge role in regulating gene expression, along 
with a huge variety of other cellular functions, and are a key player in epigenetic regulation.  
 
1.4.3 Histone Modifications 
  Histone modifications are covalent post translational modifications to histone proteins; these 
modifications can impact gene expression by altering chromatin structure (Mariño-Ramírez et al., 
2005).  The main histone modifications include histone acetylation and deacetylation and histone 
methylation. Histone acetylation is the addition of an acetyl group from acetyl coenzyme A and is 
controlled by the enzymes histone acetyltransferases (HATs), and histone deacetylases (HDACs) (Roth 
et al., 2001). Histone acetylation is generally associated with transcription, as the acetyl group 
neutralises the lysine's positive charge, weakening the interaction with DNA (Bannister and 
Kouzarides., 2011). Histone methylation mainly occurs on the side chains of arginine and lysine 
residues, and lysine residues may be mono- di- or tri- methylated (Bannister and Kouzarides., 2011). 
Methylation of histones generally correlates with a decrease in transcription of genes, as it aids in 
tightening the histone tail, restricting accesses to DNA, however, methylation of some residues in 
histones are associated with transcriptional activation (Jambhekar et al., 2019). Histone modifications 
are a classic form of epigenetic control, by modifying the chromatin accessibility dynamically.   
 
  Chromatin remodelling complexes can also configure the chromatin to permit or repress transcription. 
In mammals, the Switch/Sucrose Non-Fermentable (SWI/SNF) chromatin-remodelling complex can 
perform this. There have been two distinct SWI/SNF complexes described, each containing a unique 
domain; the BAF or PBAF domains. These domains contain recognition motifs that can bind to histone 
tails, activating or repressing them, resulting in open or closed chromatin (Alver et al., 2017).  
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1.5 Cis-Regulatory Elements (CRE) 
  The majority of the human genome consists of regions that do not code for any proteins. These non-
coding regions were described as ‘Junk DNA’ - DNA regions with no purpose.  But, in 1961 a study 
unveiled the regulatory control mechanism behind the lac operon within noncoding regions of DNA 
(Jacob and Monod, 1961), and since then many more have worked to characterise these CREs (Doane 
and Elemento, 2017). CREs are typically non-coding regions of DNA which contain binding sites for 
transcription factors (Wittkopp and Kalay, 2011). Promoters and enhancers are the best understood, but 
CREs also cover silencers and operators.   
 
  It has recently been observed that mutations within CREs are sometimes responsible for a disease 
phenotype. When screening of several human diseases showed no distinguishable mutations in the 
coding regions of their DNA, scientists turned their attention to non-coding regions of DNA. With the 
recent advances in sequencing, it was possible to sequence the whole genome, and this suggested that 
mutations within CREs were likely responsible for the disease phenotype. For example, mutations in 
an enhancer regulating expression of the SOX10 transcription factor (TF) were shown to contribute 
towards Hirschsprung disease (Lecerf et al., 2014), and recurrent mutations in the promoter regions of 
genes such as PLEKHS1 was found to be responsible for tumour progression in cancers (Weinhold et 
al., 2014). Many more diseases such as diabetes and cohesinopathies were found to contain a mutated 
variant within their associated CRE (Friedensohn and Sawarkar, 2014, Lee and Young, 2013). 
However, it is unknown how some of these CREs function, and identifying them is difficult. 
Therefore, it is important to focus efforts on identifying and characterising these CREs, to gain better 
understanding of gene regulatory networks and the control of gene expression.  
 
1.5.1 Promoters 
  Promoter regions are sequences of DNA that recruit RNA polymerase II to the transcription start site 
(TSS) of an encoded gene (Kadonaga, 2011). They are typically located directly upstream of the gene 
they are regulating and contain a conserved promoter sequence called the TATA box, which allows for 
binding of transcription factors to initiate formation of RNA polymerase transcription complex, which 
promotes transcription (Butler, 2002). Eukaryotic promoters include a core promoter, which in turn 
contains the TSS, RNA polymerase binding sites, and a TATA box (or other general TF binding sites). 
In humans, 70% of all discovered promoters contain CpG islands, which are often methylated to prevent 
expression of a gene (Deaton and Bird, 2011), a key example of epigenetic regulation. Figure 1.9 below 
gives an overview of promoter properties. 
 
 
Figure 1.9: A basic diagram depicting the main regions of a eukaryotic promoter region. The core element contains a TATA 
box and an RNA Polymerase II binding site, which recruits and binds RNA pol II to the DNA near the transcription start site 
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of the gene. This allows for transcription of the gene to initiate. Proximal promoter region is also displayed, which shows two 
other motif boxes for transcription factor binding.  
 
 
1.5.2 Silencers and Insulators 
  A silencer is a sequence of DNA that can prevent gene expression throughout differentiation and the 
cell cycle. Silencers can be located throughout the genome, however, are usually upstream of the gene 
they are acting upon, between 20bp to 2000bp, and certain silencers have been found in the 3’ UTR of 
mRNA. Currently, there are two types of recognised silencers: classical silencers and the non-classical 
negative regulatory element. Classical silencers tend to work by interrupting the formation of the 
general transcription factor assembly, by repressing the TATA box of the core promoter region, 
preventing it from recruiting and binding to RNA polymerase II (Maston et al., 2006, Ogbourne and 
Antalis, 1998).  As well as general transcription factor assembly, silencers are capable of cytoplasmic 
retention of TFs, altering chromatin structure, and can interfere with the 3’ upstream UTR signal 
recognition (Ogbourne and Antalis, 1998). They normally bind to proteins termed repressors, including 
polycomb complexes PRC1 and PRC2, which remodel chromatin to prevent access of transcription 
machinery to the desired loci (Kanhere et al., 2010). Silencers that are located a long way from the 
promoter region it is repression will target that promoter through looping of the DNA, where the silencer 
element is brought into close proximity with the promoter region (Kolovos et al., 2012).  
 
  One example of a characterised classical silencer regulates the human thyrotropin gene-β gene. It is 
found in the hTSHβ promoter region, where it acts upon an AT-rich octamere-1 (OCT-1) binding 
domain. It is believed that the silencer recruits oct-1, which can silence transcription by interfering with 
TFIIH, preventing helicase activity (Kim et al., 1996). NREs physically inhibit the interaction of TFs 
with their binding sites or interfere with specific signals that control transcription events (Ogbourne and 
Antalis, 1998). Silencers are an important part of genetic regulation and will also be depicted as an open 
peak during ATAC-sequencing, so it is important to understand them for this experimental pipeline.  
    
1.5.3 Enhancers  
  In 1981, distal cell specific regions of open chromatin were identified far from any expressed genes. 
It was shown that these regions ‘enhanced’ gene expression in cis, and the term enhancer was first used 
(Banerji et al., 1981).  It is currently believed that the human genome contains roughly 500,000 
enhancer regions, which are used to regulate gene expression during development and homeostasis 
(Gasperini et al., 2020). Enhancers are defined as short sequences of DNA that contain transcription 
factor binding motifs that increase the likelihood of transcription of one or more genes through a cis 
regulatory mechanism (Ong and Corces, 2011). However, despite the obvious importance of enhancers 
to both disease biology and fundamental biology, far more work is needed to fully characterise and 
understand the functional importance of these regions.  
 
  There are a few distinguishable characteristics of enhancer regions. They are usually linked with 
certain properties of chromatin, and active enhancers are typically bound by transcription factors. 
Regions that flank enhancers are marked by histone modifications which allow for open chromatin 
complexes such as H3K4me1 and H3K27 acetylation, with a depletion of H3K4me3 (Calo and 
Wysocka, 2013, Jin et al., 2009).  The TSS of enhancers are depleted of nucleosomes, and are therefore 
sensitive to DNase I digestion, and many functional enhancers contain dynamic nucleosomes (Thurman 
et al., 2012). Other markers, such as the proteins Cyclic AMP-responsive element-binding (CREB) and 
P300 are also characteristic of some enhancer regions. (Mayuranathan et al.,2015) and in-vivo mapping 
of P300 binding sites in mouse accurately identified novel enhancers (Reviewed in Ong and Corces, 
2011). Most enhancer regions are also bound by chromodomain helicase DNA binding protein 7, 
cohesin, mediator subunits and CCCTC-binding factor (CTCF) (Zentner et al., 2011).  
  
As enhancers work spatio-temporally to regulate gene expression, they are found in different states 
depending on chromatin accessibility. Developmental enhancers undergo progressive changes that 
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depend on TF activity and chromatin remodelling (Peng and Zhang., 2018), and thus there are three 
characterised states of enhancers. Active enhancers that interact with their respective promoter have 
chromatin modifications that allow transcription factors to bind to the enhancer region. Prior to 
activation, enhancers can exist in two states; primed or poised. Many TFs can bind to enhancers and 
trigger nucleosome repositioning to increase accessibility to other factors (Zaret and Carroll, 2011). 
These TFs are termed pioneering factors and can bind to DNA that is inaccessible to other factors, and 
recruit chromatin remodelling complexes (Biddie et al., 2011). One of the most studied pioneering 
factors is FOXOA1, which induces chromatin remodelling (Lupien et al., 2008). The binding of a 
pioneer factor is not sufficient to form an active enhancer, and so this state is termed primed. It is 
believed that primed enhancers arise as a result of developmental progression, where pioneering factors 
that are produced by one developmental genetic process can then act on an enhancer to regulate gene 
expression of a gene that is required later in development. Poised enhancers have not been extensively 
studied but have been identified in mouse and human embryonic stem cells and are still able to interact 
with their corresponding promoter, in preparation for activation (Creyghton et al., 2010). Figure 1.10 
below shows these three states of enhancers, and the chromatin modifications associated with these.  
 
 
Figure 1.10: Diagram explaining the different chromatin features associated with active poised and primed enhancers. A) 
Active; The histones flanking the enhancer regions are marked with the modifications H3K27ac and H3K4me1. There is an 
incorporation of hypermobile nucleosomes containing the H3.3/H2A.7 modifications. B) Primed; this state is characterised 
by the presence of H3Kme1, with no nucleosome incorporation. This state does not interact with the promoter but binds the 
pioneer factor FOXA. C) Poised; this state is found in human and mouse embryonic stem cells. These enhancers are associated 
with PCR2 and interact with their promoter.  
 
  It was initially thought that enhancers worked by direct interactions with RNA polymerase II, yet now 
it is believed that enhancers work by an indirect interaction (Kolovos et al., 2012).  To increase the 
likelihood of transcription of a gene, the enhancer must interact with its respective promoter, which 
could be located many base pairs away. It has been demonstrated in the β-globin locus that DNA looping 
brings the enhancer and the promoter regions into close proximity by ‘looping out’ intervening DNA 
(Krivega and Dean, 2012). Experiments including the chromosome conformation capture 3C (and later, 
4C and 5C) confirmed this theory (de Wit and de Laat, 2012). The mechanism of DNA looping is 
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displayed in figure 1.11. It is currently thought that DNA binding TFs bound at both the promoter and 
the enhancer recruit ‘looping factors’ that help to form the loop (Krivega and Dean, 2012).  
 
  Genomes also contain insulators that regulate enhancers. Insulators are protein-DNA complexes that 
prevent enhancers from activating a gene, however, they are also involved in chromatin looping. In 
vertebrates, the only known insulator protein is CTCF, which recruits a protein called cohesin 
(Merkenschlager and Odom, 2013). Cohesin belongs to the family of SMC (structural maintenance of 
chromosomes) protein complexes, which are ring shaped ATPases that encircle DNA (Kagey et al., 
2010). Recent studies have demonstrated the binding sites that regulate cohesion during genetic 
regulation. Normally, cohesin binds to CTCF, however, numerous and often weaker cohesion sites map 
to active enhancers and promoters, where it colocalizes with its loading factor Nipbl, mediator 
components and tissue specific transcription factors (Schmidt et al., 2010). The first time the cohesin- 
CTCF long range interactions was demonstrated to be of significance was in the mouse lfng locus. A 
CTCF binding site 60kb upstream of the lfng coding region interacts with two other CTCF binding sites, 
one in the first intron of the gene, and one 100kb downstream of the gene. These long-range interactions 
are required for lfng expression, which requires both CTFC and cohesin (Hadjur et al., 2009, Sekimata 
et al., 2009). Along with this, cohesion depletion was shown to disrupt promoter-enhancer interactions 
in embryonic stem cells (Kagey et al., 2010). The mechanism of looping of DNA requires insulator 
regions and cohesin, and this mechanism is crucial to our understanding of enhancer function, bringing 
the enhancer region and its associated transcription factors into close contact with promoter regions. 
 
  The transcription factors and complexes that may mediate the enhancer-promoter looping have only 
been identified in a few examples. In the well characterised β-globin locus, a reduction of the GATA-
1, EKLF and Ldb1 transcription factors resulted in failed β-globin activation or looping between the 
gene and the locus control region (Vakoc et al., 2005). Other general transcription factors that are 
required in specific cases for enhancer-promoter communication include OCA-B, TFII-I, and STAB1, 
which when reduced leads to a compromised loop formation and transcription (Ren et al., 2011, Gong 
et al., 2011, Cai et al., 2006). There is a clear lack of understanding in how enhancer- promoter 
interactions are formed through the looping mechanism, and more work is needed to fully understand 




Figure 1.11: A simple diagram demonstrating the looping of DNA. Cohesin binds to CTFC factors on the DNA forming a ring 
and looping out the intervening DNA between the enhancer and the promoter region. Own image.  
 
Enhancers can regulate the spatial expression of genes. It is known that more than one enhancer can 
mediate the expression of one gene, which gives rise to complex patterns of gene expression (Perry, 
Boettiger and Levine, 2011). This can result from the additive action of different enhancers with cell 
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type or tissue specific activities and gene expression (Barlow, 2011). There are ‘primary’ and 
‘secondary’ enhancer regions, with the secondary enhancer often being described as a shadow enhancer 
(Barolo, 2011). It is currently thought that the presence of two enhancers with overlapping activity can 
provide a robustness to gene expression, establishing precise boundaries of gene expression (Frankel et 
al., 2010). In mouse embryos, Shh transcription is controlled by two enhancers. When activated by the 
two distinct enhancers, expression is restricted and robust in the floor plate. However, transcription in 
the limb bud is controlled by only one enhancer and gives a more sporadic expression pattern (Amano 
et al., 2009).  
 
  The identification of enhancers has proved challenging in the past for several reasons. Firstly, 
enhancers are scattered throughout the non-coding regions of the genome, resulting in a large search 
area (Gasperini et al.,2020). Whilst it is known that enhancers work in cis, they can be located many 
base pairs away from the promotor they are working on, bypassing their closest promoter (Spilianakis 
et al., 2005). Secondly, and whilst some enhancers have chemical properties that have been annotated 
(discussed above), there is no underlying feature that can identify an enhancer sequence based on DNA 
sequence alone. Along with this, DNA sequence conservation in these regions is often poor, as only 
very specific TF binding sites are required. Thirdly, some enhancers have been shown to regulate 
activity of two or more promoters, further adding complexity when attempting to identify and 
functionally characterise enhancers (Karnuta and Scacheri, 2018). Finally, the activity of enhancers is 
usually spatially and temporally restricted, meaning they are difficult to discover if the method used 
does not capture the enhancer activity in the correct tissue or at the correct developmental time point 
(Karnuta and Scacheri, 2018).     
 
  Despite these difficulties, many attempts have been made at identifying enhancer elements. Several 
different technologies have been developed to characterise enhancer regions, each with varying levels 
of success. Firstly, the DNA sequence of a candidate enhancer region can be studied, using sequence 
conservation and candidate regulatory elements for TF binding, for example, scanning the genome for 
regions with p300 binding sites. However, not all enhancers are conserved, and not all motifs for TF 
binding are known or perfectly annotated. Furthermore, the presence of a TF motif does not indicate 
functional binding of the TF. Therefore, predicting candidate enhancer regions based purely on 
sequence alone is limited. 
 
 As enhancers rely on binding of TFs and chromatin accessibility to become active, genome wide 
methods that determine TF binding sites or chromatin modifications are often used. These methods 
include FAIRE-seq, ChIP-seq, DNA adenine methyltransferase identification (DamID), DNAse-seq, 
and STARR-seq. These methods are further described below.  
 
  Chromatin immunoprecipitation and sequencing (ChIP-seq) for transcription factors, mediators, and 
cofactors such as P300 (Visel et al., 2009), and histone modifications such as H3K4me1 and H3K27ac 
(Creyghton et al., 2010, Cheung et al., 2020) is one of the main methods used to attempt to identify 
enhancers. The ChIP-seq approach is dependent on cross-linking of proteins to specific DNA elements, 
then the addition of an antibody specific for the protein-DNA complexes, followed by high throughput 
sequencing of recovered DNA fragments (Creyghton et al.,2010). Again, the downside of this is that 
the TF must be bound to the DNA sequence, or the histone modification must be present, meaning the 
enhancer region must be active. However, while ChIP-seq successfully recovers the most enhancer 
regions, some regions sequenced are not enhancer regions. This is because TF can bind to other regions 
of DNA, and as there is not one TF that binds to only enhancers, ChIP-Seq is captures some other 
protein-DNA interactions that are not enhancers. The use of the cofactor P300, for example, has been 
highly successful in identifying enhancer regions, as 58-82% of the P300 binding sites have been 
associated with functional enhancers (Blow et al., 2010).Other methods that work similarly to this 
include ChIP-exo, which allows the identification of TF binding sites at higher resolution due to the 
addition of exonuclease digestion (Rhee and Pugh, 2011), and DamID, which can be used if antibodies 
for the protein of interest aren’t available as an alternative to ChIP-seq (Steensel and Henikoff, 2000).   
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  Predictions using genome accessibility have also been used. In general, the regulatory elements 
selectively localise in the accessible chromatin (Thurman et al., 2012). This is because accessible 
chromatin is required for transcription factor binding, whereas condensed chromatin restrict binding of 
TFs and transcriptional regulators to the promoter and enhancer regions. There are several techniques 
that can be used to digest nuclear DNA. In the past, experiments using DNase I (Chen, et al., 2018), 
micrococcal nuclease (MNase) or MPE-FE (Ishii, et al., 2015) coupled with sequencing would identify 
regions of accessible chromatin. An alternative to DNase-seq; formaldehyde-assisted identification of 
regulatory elements (FAIRE-seq), determines open regions of chromatin by depleting histone-bound 
closed DNA after crosslinking with formaldehyde (Simon et al., 2012).  Although active enhancers are 
found in regions of accessible chromatin, not all accessible regions correspond to an enhancer; for 
example, the TSSs within a promoter are nearly always accessible.  
 
  Assay for transposase accessible chromatin (ATAC) sequencing is a relatively new method that also 
works to identify open chromatin regions but is faster and more sensitive than DNase-seq and other 
predecessors. ATAC-seq uses the transposase 5 (Tn5) enzyme found in bacteria which recognises open 
regions of chromatin, where it cleaves and tags DNA with sequencing adapters. These tagged regions 
of DNA are then purified, PCR amplified and sequenced using next generation sequencing (NGS) 
(Buenrostro et al., 2014). Sequencing reads can then be used to map regions of TF binding sites and 
nucleosome positions, and the number of reads for a particular region correlates with how open the 
chromatin is. The hyperactivity of the Tn5 transposase makes the ATAC-sequencing protocol simple 
and time efficient, requiring only 500-50,000 cells (Buenrostro et al., 2014). Figure 1.12 below depicts 
the process of ATAC-sequencing. More recently, the new method single-cell-ATAC-seq (scATAC-
seq) has been described, which relies on using fluorescence-activated cell sorting (FACS) and nono-
well-based approaches (Buenrostro et al., 2015, Mezger et al., 2018). This is useful in studying 
heterogenous cell populations at a single cell resolution and could be extremely useful in depicting the 




Figure 1.12: Diagram depicting the process of Assay for Transposase Accessible Chromatin. The Tn5 transposase enzyme 
binds to regions of open chromatin and cuts, adding sequence adaptors to the end. Next Generation Sequencing is used to 
read these segments, which are then mapped to the genome. Open regions are visualised as a peak.  
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  Expression quantitative trait locus (eQTL) can be used to characterise distally located putative 
regulatory elements. It works by testing for correlation between genotypes (tested by genome 
sequencing) and the location of genes in cis (measured by bulk RNA-seq). Variants that are associated 
with gene expression differences are described as eQTLs. Variants residing within distally located 
putative enhancers can be linked to their target genes and validated in vivo. The eQTL framework is a 
powerful and novel tool in identifying and characterising enhancers (van der Wijst et al., 2018, Strober 
et al., 2019).   
 
  Another way to identify an enhancer is based on their looping method of interacting with their 
respective promoter region. By using 3C (Chromatin Conformation Capture) methods, high resolution 
3D conformational maps are produced.  These maps are produced by the cross-linking of cells by 
formaldehyde, followed by chromatin isolation and digestion. The digestion occurs through the use of 
a restriction enzyme that recognises and cuts regions of DNA which, mediated by a protein complex, is 
interacting with another region of DNA. These fragments are ligated, and the crosslinking procedure 
reversed. RT-PCR is then used to determine the quantity of ligation product. This directly correlates 
with the interaction frequency between the two ligated regions (Dekker, 2006). The resulting datasets 
have led to the identification of TADs, and enhancer-promoter loops. This 3C method can be coupled 
with biochemical assays such as ChIA-PET and DNase Hi-C to help identify regions with functional 
interactions. Other variations of 3C have been produced, including Circularize Chromosome 
Conformation Capture (4C) and Carbon Copy Chromosome Conformation Capture (5C), which can be 
used to gain larger and clearer conformation maps. Figure 1.13 depicts all the different methods that 
can be used to identify regulatory elements.  
 
 
Figure 1.13: A simple diagram showing the different methods that can be used to attempt to identify enhancer regions. 
  There are several projects that all aim to map the functional elements within the human genome, using 
the techniques described above. The Encyclopaedia of DNA Elements (ENCODE) has been running 
since 2007 which combines a large number of sequence-based studies to discover potential elements 
(The ENCODE Project Consortium., 2012). Approaches used include RNA-seq, CAGE-seq (which 
maps TSS of transcribed genes), ChIP-seq, FAIRE-seq, DNase-seq and an assay to find methylation 
sites (RBBS assay). Other programmes that do similar things include FANTOM5, VISTA ENhancer 
Browser, Enhancer Atlas and HEDD (Peng and Zhang, 2018). However, only 26% of the candidate 
enhancers predicted by the data generated in ENCODE and only 50% in VISTA Enhancer Browser 
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displayed functional enhancer activity with reporter assays (The ENCODE Project Consortium., 2012, 
Kwasnieski, et al., 2014). Accurately validating and characterising enhancer elements remains a 
challenge, and clearly more work needs to be done to help identify key markers of enhancers and their 
functional significance.  
 
1.5.4 Characterisation of Enhancers 
  There are several different ways to test enhancer activity and function. One of the most common ways 
is imaged based enhancer testing in developing embryos, where the candidate enhancer DNA is placed 
upstream of a minimal promoter and a reporter gene. The abundance and localisation of the reporter 
transcript displays the enhancer activity. The reporter gene can include an enzymatic reporter (luciferase 
or β-galactosidase), fluorescence, such as GFP or specific antibodies (Visel et al., 2007, 2009). 
However, for this method to work, the generation of transgenic animals must occur, making it unsuitable 
for large scale enhancer screening. To combat this, various methods have been developed using 
plasmid-based systems to assess enhancer activities. Again, each candidate enhancer region is placed 
upstream of a minimal promoter and a reporter gene. These are then electroporated into embryos, 
allowing cells to take up the reporter plasmid. If the candidate enhancer construct is expressed, the 
reporter gene will display spatially and temporally throughout the embryo (Rada-Iglesias et al., 2010).    
 
  Massively parallel reporter assays (MPRAs) can test the functionality of thousands of putative 
enhancer regions in one experiment. A library of candidate enhancers is cloned into a reporter vector, 
with a minimal promoter. Each reporter gene transcript includes a DNA barcode that is associated with 
a particular enhancer. The relative abundance of each RNA barcode is used to quantify the activity of 
its cognate candidate enhancers. MPRAs can test large numbers of putative enhancers using relatively 
simple techniques). STARR-seq (Self-Transcribing Active Regulatory Region Sequencing) is a 
technique whereby candidate sequences are cloned downstream of the core promoter into 3′UTR of a 
reporter gene’s, making the candidate sequence part of the reporter genes’ transcription unit. Candidates 
that are active enhancers will lead result in the transcription of reporter mRNAs that are the candidates’ 
sequences. This straightforward technique allows for assessment of millions of candidate enhancer 
regions in parallel by quantifying the reporter mRNAs by deep sequencing (Muerdter, Boryń and 
Arnold, 2015).  
 
  CRISPR screening for enhancers is a relatively new technique, due to improvements in the CRISPR 
methodology. CRISPR screens work with the aim of characterising massive numbers of enhancers, by 
delivering a library of enhancer targeting guide RNAs (gRNAs) to cells. These gRNAs will disrupt their 
target putative enhancer region by creating a small cut, which through inaccurate repairing of the DNA, 
will result in the formation of an indel, which may disrupt the regulatory element’s function. The 
phenotypic result from these screens informs researchers which gRNAs affect gene expressions (Diao 
et al., 2016). This method has the potential to link candidate enhancer regions to their target genes.  
  
  
1.6 Genes Involved in Somite Differentiation   
  Previous work in the lab has resulted in the generation of both RNA-sequencing and ATAC-seq 
datasets. They were constructed by removing somites of different levels of differentiation (Pre-somitic 
mesoderm, epithelial somite, maturing somite and differentiated somite) from a HH14 chick embryo 
and performing both RNA and ATAC-seq on these dissected regions.  Genes were chosen from the 
RNA-sequencing that showed similar expression patterns to MyoD for muscle markers. For tendon and 
cartilage markers, genes that were found from literature to be of interest were reviewed in the RNA-
sequencing dataset for high levels of expression.  With each of these genes, the ATAC-sequencing 
dataset was analysed to identify their respective candidate enhancer regions. 
 
1.6.1 FOXO1  
  Forkhead box protein O1 (Foxo1) is a protein encoded by the Foxo1 gene found on chromosome 13 
in the human genome and chromosome 1 in the chicken genome (Sanchez et al., 2013). The FoxO 
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family of proteins are transcription factors, characterised by a distinct fork head domain. They are key 
downstream targets of the P13-Kinase/PKB signalling pathway, and their transcriptional activity is 
controlled by phosphorylation (Sanchez et al., 2013). Phosphorylated FoxO proteins are confined to the 
cytoplasm and are thus rendered incapable of regulating transcription in the nucleus. Foxo1 has a wide 
variety of roles, perhaps best known for its regulation of gluconeogenesis and fate determination of a 
preadipocyte to commit to adipogenesis (Nakae et al., 2003). Due to this, it has been identified as a 
potential genetic control for type II diabetes.    
 
  Foxo1 also has a role in regulation of muscle differentiation and fibre type specification, with a specific 
role in myoblast fusion and differentiation (Yamashita et al., 2016). It is believed that myogenic 
differentiation requires Foxo1 inhibition. Foxo1 gain of function mutants in C2C12 cells demonstrated 
inhibition of myoblast differentiation and blocked myotube fusion, whereas transcriptionally inactive 
Foxo1 cell lines displayed an increase in the expression of muscle differentiation markers, including 
myogenin and MyHC (Hribal et al., 2003). Transgenic mice overexpressing Foxo1 display less skeletal 
muscle mass, with paler muscles and a downregulation of genes related to structural proteins of muscles 
(Kamei et al., 2004).  Whilst previous research has demonstrated the expression pattern of Foxo1 gene 
in other model organisms (Zheng et al., 2020, Baek et al., 2018, Villarejo-Balcells et al., 2011), there 
was no expression data for Foxo1 in chicken embryos. Although Foxo1 suppresses early myoblast 
differentiation, Foxo1 is required for myoblast differentiation into myotubes. This mechanism is 
currently poorly understood, and it would be interesting to further characterise this protein and its 
biological regulation.  
 
1.6.2 UNCX 
  UNCX is a paired homeobox gene, which codes for a transcription factor that is involved in 
somitogenesis and neurogenesis (Mansouri et al., 1997). UNCX gene in gallus gallus is homologous to 
UNCX4.1 in mammals, such as humans and mice. UNCX plays many roles during the development of 
the central nervous system (Sammeta et al., 2010), with high levels of expression in the olfactory 
sensory neurons, and in the neural progenitor cells of the dorsal neural tube, which gives rise to the 
spinal cord and the telencephalon (Neidhardt et al., 1997). However, UNCX is best known for its role 
during early somitogenesis. UNCX is normally confined to the caudal half of the somite and sclerotome, 
suggesting a role for initial rostral-caudal somite patterning (Evrard et al.,1998), specifically to maintain 
the condensation of the caudal half sclerotome (Mansouri et al., 2000). Loss of function experiments in 
mice show a disruption in the establishment of antero-posterior somite polarity, and display severe 
malformations of the axial skeleton, especially in the ribs (Leitges et al., 2000, Mansouri et al., 2000). 
In knockout mouse embryos,expression of Pax9 is lost in somites after the first three somites form, 
suggesting that UNCX maintains expression of Pax9 in the lateral sclerotome.  
 
  Repression of UNCX expression in the anterior somite is controlled by a regulatory network involving 
the transcription factor Mesp2, Ripply and MEOX1 (Takahashi et al., 2013), and is negatively regulated 
by Tbx18 (Nittoli et al., 2019). Understanding the regulatory mechanisms that underlie expression of 
UNCX would give insight into the mechanisms of early somite formation and rostral-caudal patterning.  
 
1.6.3 KLHL31 
  Klhl31 belongs to the family of Kelch proteins, a functionally diverse and highly conserved set of 
proteins, all characterised by the presence of a Kelch-repeat domain and the BTB (Bric-a-brac, 
Tramtack, Broad-complex) domain (Adams et al., 2000). Members of this family are involved in 
numerous cellular processes, including protein degradation, gene expression and cell migration (Shibata 
et al., 2013., Lührig et al., 2013). The kelch protein was first discovered in Drosophila melanogaster, 
where females carrying a mutation in the kelch gene became sterile, due to issues with cytoplasm 
transport throughout oogenesis (Schupback and Wieschaus., 1991). Since the discovery of Kelch, a total 
of 41 kelch-like proteins were identified in humans, where they are identified with numerous roles in 
skeletal muscle development and disease (Gupta and Beggs, 2014).  
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  Klhl31 was first discovered in zebrafish, where there were high expression levels in skeletal and 
cardiac tissues (Wu and Gong, 2004), with further work describing a similar pattern of expression in 
humans. Work previously conducted in the Münsterberg lab showed expression of Klhl31 in the 
mesoderm of the anterior intestinal portal, starting at HH8, and in cardiac progenitors from HH9 (See 
figure 1.14). Klhl31 was then expressed in the myotome and continued strong expression patterns in all 
skeletal muscle tissues (Abou-Elhamd et al., 2009). This paper also described its regulatory pathway; 
rescue experiments in the myotome showed Klhl31 is downstream of Wnt-1 and Myf5. The expression 
of Klhl31 is initiated by the transcription factor MEF2, just after MyoD in developing skeletal muscles, 
implying the involvement of Klhl31 in early myogenic commitment and differentiation (Liu et al., 
2014). Deletion of Klhl31 in mice results in sarcomeric degeneration and stunted postnatal skeletal 
muscle growth, which highlight a role of Klhl31 in the maintenance of muscle structure (Papizan et al., 
2017). Other studies suggest that the Klhl31 protein acts as a transcriptional repressor in the 
MAPK/JNK signalling pathway, due to its BTB domain repressing GAL4 DNA binding domains of 
both the TPA-response element (TRE) and the serum response element (SRE) (Hu et al., 2010).  
 
 
Figure 1.14: In situ hybridizations with Klhl31 antisense RNA probes on whole mount embryos, with images of cryosections. 
Image taken from Abou-Elhamd et al., 2009. 
  Other previous work done on embryos during targeted knock down of Klhl31experiments using 
antisense morpholinos lead to an increase in the number of mitotic cells in the myotome, whilst mis-
expression of Klhl31 lead to a reduced size of myotome (Abou-Elhamd et al., 2015). This work suggests 
the importance of Klhl31 during muscle development. Experiments done to understand the underlying 
mechanisms demonstrated the Klhl31 interferes with β-catenin dependent Wnt signalling.   
 
Klhl31 has previously been intensively studied in the Münsterberg lab due to its role in myogenesis 
(Abou-Elhamd et al., 2009., and 2015), and further characterisation of the mechanisms of its regulation 
by enhancer activity could prove useful in gaining a broader view of muscle development.  
 
Page | 27  
 
1.6.4 ALX1  
  The Alx1 gene (also known as CART1) belongs to the aristaless-like homeobox family of proteins, 
which directs the formation of structures during early embryonic development (Ettensohn, 2003). The 
Alx1 protein is a transcription factor, required for normal formation of the craniofacial region (Lyons 
et al., 2016). Three mutations found within this gene result in extreme frontal dysplasia type three, with 
individuals carrying this mutation displaying severe malformations of the face, including clefts (Uz et 
al., 2010). However, this gene also has links to skeletal muscle development. In sea urchins, Alx1 
expression is restricted in the skeletal micromeres and the cellular descendants of this lineage, which 
become the skeletal mesenchyme (Ettensohn, 2003). In mouse embryos, expression is restricted to the 
craniofacial region and the limb buds (Beverdam and Meijlink, 2001).  
 
  Morpholino antisense interference experiments have suggested Alx1 expression is driven in skeletal 
mesenchymal cells by the ETS1 transcription factor (Damle and Davidson, 2011), and the MO- injected 
embryos were not able to differentiate skeletal mesoderm in sea urchins (Ettensohn, 2003).  In chickens 
with abnormal face structures, for example, a duplicated beak, Alx1 expression is increased or altered 
(Buchtová et al., 2009). Alx1 is also responsible for the diversification of beak shape within Darwin 
finches, again showing the evolutionary importance of this gene (Lamichhaney et al., 2015).   
 
  Interestingly, in early development, Alx1 RNA expression has been detected in pre-chondrocytic 
mesenchymal cells responsible for the formation of cartilage, and later in the tendons and limb buds 
(Zhao et al., 1994).  Embryos with an Alx1 mutation display polydactyly, and other limb deformities, 
suggesting a role in the formation of the limb. Alx1 may be interesting for further study due to its high 
expression in somites at HH14 and understanding its importance in early development will further aid 
our understanding of muscle and craniofacial development.  
 
1.6.5 Scleraxis 
  The scleraxis (scx) gene codes for a protein that is a member of the basic helix-loop helix (bHLH) 
family (Cserjesi et al., 1995), which all contain a highly conserved domain, includeing a stretch of 
amino acids adjacent to two ALPHA-helices separated by a loop. These proteins typically form 
heterodimers and bind to DNA with the consensus sequence known as an E-box. Members of the bHLH 
family have been shown to play roles in regulation of growth and differentiation of cell lineages (Jones 
2004).  Other members of this family include the well characterised myogenic regulatory factors MyoD, 
myf5 and myogenin.  
 
  Scleraxis is expressed in the syndetome compartment of somites, which give rise to ribs and vertebrae 
(Cserjesi et al., 1995), and is also expressed in all cells of a tendon and ligament lineage (de 
Crombrugghe et al., 2000., Perez, et al., 2003) (see figure 1.15). The first look at the gene regulatory 
network controlling Scx induction demonstrated that removal of the dermomyotome results in no 
induction of Scx, and that fibroblast growth factors (FGFs) secreted from the myotome induce the 
anterior and posterior sclerotome to adopt the syndetome fate (Brent et al., 2003). It was found that the 
two important FGFs for inducing syndetome and scx were FGF4 and FGF8, where overexpression 
results in ectopic scx expression throughout the entire sclerotome (Brent et al., 2003, Edom-Vovard et 
al., 2002). Interestingly, the FGF receptor FREK expression is localised to the anterior and posterior 
myotome borders, the location of the syndetome (Kahane et al., 2001). Further study went on to prove 
that the Ets transcription factors Pea3 and Erm respond to FGF signalling to induce Scx expression 
(Brent, 2004).  
 
  Scleraxis knockout experiments produce embryos with severe defects to the force transmitting and 
intermuscular tendons (Murchison et al., 2007), and a loss of distal rib development (Smith et al., 2005). 
However, the ligaments and muscle anchoring tendons remain unaltered (Murchison et al., 2007), 
suggesting that whilst scleraxis is a faithful marker of the lineage, it is not required for the complete 
development of all tendons.  
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  Scleraxis has multiple downstream targets that contribute towards the regulation of tendon formation. 
Scleraxis can activate the collagen type 1 alpha 1 proximal promoter in-vitro (Lejard et al., 2007). Scx 
can positively regulate the expression of Tendomodulin (Tnmd), a marker of differentiated tenocytes 
(Shukunami et al., 2006), and Mohawk (Mkx), along with upregulating the expression levels of 
proteoglycans found in the tendon matrix (Alberton et al., 2012).   
 
 
Figure 1.15: B) Whole mount in situ- hybridisation with the Scleraxis cDNA probe on a HH20 chicken embryo. E) Frontal 
cryosection image through a stage 24 embryo. Somites stained with MF20 antibody to visualize the myosin heavy chain 
protein, which is displayed throughout the myotome. Red staining shows Scleraxis transcripts. Taken from Smith et al.,2005.   
  Scleraxis plays an important role in tendon formation, and previous publications have attempted to 
locate the cis-regulatory element for scleraxis (Perez et al., 2003), however, were only successful in 
identifying a region that when deleted resulted in a lack of scx expression in mice. Proper 
characterisation of a scleraxis regulatory element in chicken development would further our 
understanding of the regulatory networks involved in tendon development and the gene regulatory 
network influencing the expression of scleraxis.      
 
1.6.6 Mohawk  
  Homeobox protein Mohawk (Mkx) is a member of the TALE superclass of atypical homeobox genes, 
related to the iroquois family of proteins, and regulates tendon differentiation during embryological 
development. During mouse development, Mohawk is expressed in the syndetome at embryonic day 9, 
skeletal muscle and the sex chords of the male gonad, and the transcription of Mkx requires Paraxis 
(Anderson et al., 2006). Mkx-/- mice contain hypoplastic tendons throughout the body, along with a 
down regulation of type 1 collagen in tendons, and drastically reduced size of tendons (Ito et al., 
2010).  Mkx overexpression suppresses chondrogenic differentiation while Mkx deficiency results in 
chondrogenic differentiation, suggesting that Mkx has many roles, such as differentiating tendons and 
in suppressing chondrogenic differentiation (Suzuki et al., 2016).  
 
  In addition to this, Mkx negatively regulates myogenic differentiation, through a conserved sequence 
named Mohawk Repressor Domain1, 2 and 3 (MRD1,2 and 3) (Anderson et al., 2007). Mohawk also 
represses myogenic differentiation by association with the co-repressor complex Sin3A Histone 
Deacetylase (Adams et al., 2018) and polymerase II general transcription factors, such as TFIIA1, 
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TFIIB and Tbp (Anderson et al., 2009). Binding to these transcription factors results in gene silencing, 
due to the inability of the RNA polymerase II formation at transcription start sites (Heinzel et al., 
1997).   
 
  Most importantly, it has been shown that through using these repressive controls, Mkx is able to repress 
MyoD, a gene known for its role at the top of the myogenic differentiation pathway. It was shown that 
in 10T1/2 fibroblast cells expressing MyoD that were exposed to full length Mxk transcript the number 
of muscle specific protein myosin heavy chain were reduced drastically. It also reduced the number of 
myotubes than the cells expressing just MyoD. The expression of both Mkx and MyoD resulted in a 47% 
reduction of the number of MHC-positive myotubes when compared to just MyoD alone (Anderson et 
al., 2009). Mohawk plays a large role in tendon differentiation, and identifying any enhancers associated 
with it would further our understanding not only of the tendon differentiation pathway, but also the 
chondrogenic and myogenic pathways.    
 
1.6.7 TN-C 
  Tenascin C (TN-C) is a glycoprotein that is the founding member of the tenascin gene family. It was 
chosen as a tendon and cartilage differentiation marker as it is expressed not only in embryogenesis, 
but also in adult tendons (Saunders et al., 2012). TN-C appears to play a role in early differentiation 
events, as one of the earliest markers of maturing tendons and cartilage and can stimulate 
chondrogenesis in vivo (Gluhak et al. 1996). During early limb development, Tenascin-C is selectively 
associated with condensing chondrogenic mesenchyme (Mackie and Murphy, 1998). TN-C in tendons 
is a direct key target of Scx, where it binds to a variety of other extracellular matrix proteins, such as 
collagen and fibronectin (Chen et al., 2016) Mutations within the TN-C gene have been associated with 
Achilles tendinopathy, where the body cannot repair any damage done to the Achilles tendon (Saunders 
et al., 2012), and tendon ruptures.  
 
  TN-C is an interesting gene to understand as it marks the transition into mature tendons and 
chondrocytes. Investigating enhancer regions for this gene could further our understanding in what 
regulates the transition of chondrocytes and tenocytes into mature, fully functioning cartilage and 
tendon cells.   
 
1.6.8 Pax1 and Pax9  
  Pax1 is a member of the paired box family of highly conserved transcription factors, characterised by 
the presence of the DNA binding domain called the paired box. This family of proteins were originally 
discovered in Drosophila, but are conserved throughout nearly all species, and are associated with 
pattern formation during vertebrate development (Wallin et al., 1994). Pax1 is well known for its role 
in the development of the ventral vertebral column (Peters et al., 1999), and mutations within this gene 
often lead to diseases associated with malformation of the spinal cord, including Jarcho-Levin syndrome 
(Bannykh et al., 2003) and Kippel-Feil syndrome (McGaughran et al., 2003). However, Pax1, along 
with Pax9 plays a major role in chondrogenesis, and is highly expressed at early stages of embryo 
development in the sclerotome (Peters et al., 1999), see figure 1.16. Experiments done in embryos 
deficient for both Pax9 and Pax1 shows defects with condensation of the sclerotomal cells around the 
notochord, along with a decrease in sclerotomal cell proliferation, and thus chondrogenesis is not 
initiated (Peters et al., 1999).  
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Figure 1.16: Above: Whole-mount in-situ hybridisation at HH 13 showing detection of Pax1 mRNA in the somites and the 
branchial arches. Below: Cryomount section of this in-situ hybridisation, showing Pax1 hybridising to the sclerotomal regions. 
Images taken from the Geisha database (http://geisha.arizona.edu/)  
  Pax1 and Pax9 are two key genes involved in sclerotomal fate. Along with this, a downregulation of 
Pax1 and Pax9 are crucial for the formation of the syndetome. These two genes are early regulators of 
both cartilage and tendon fate and understanding regulation of these genes will aid our knowledge of 
sclerotomal and syndetome formation. 
 
1.6.9 MEOX2 
  Mesenchyme homeobox 2 (Meox2) is a transcription factor that specifies mesodermal tissue that is 
fated to become the muscle lineages (Valcourt et al., 2007) (see figure 1.17). Knockout of Meox2 in the 
mouse leads to a reduction of muscle mass and a loss of specific muscle types from the limbs (Mankoo 
et al., 1999). They also develop cleft palate due to a lack of mesenchymal cells in the region of palatal 
fusion (Jin and Ding, 2006). Mef2 regulates Meox2 expression during myogenesis and is also a gene 
target of the TGFβ signalling pathway (Valcourt et al., 2007). Meox2 also binds to an enhancer that 
regulates the expression of the Myf5 gene and is required for activation of Myf5 activation in the 
myotome (Daubas et al., 2015). 
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Figure 1.17: A) Whole mount in-situ hybridisation on HH.13 and B) HH.17 chicken embryo hybridising to Meox2 mRNA. 
Expression of Meox2 is found in the neural tube/plate, as well as the somites. Images acquired from Geisha database 
(http://geisha.arizona.edu/). 
1.7 The Chicken as a Model for Development  
  The use of chick as an experimental model for researching developmental processes has led to some 
major discoveries. Experiments in chicken embryos have contributed significantly to understanding 
embryology, including the understanding of Left/Right asymmetry in the placement of internal organs 
(Raya et al., 2004), and experiments that revealed the signalling pathways in the limb (Towers and 
Tickle, 2009). Chicken embryos are used for several reasons; the chicken egg is a common and available 
source, allowing for quick experimentation. Chick embryos take only three weeks to fully develop and 
can be brought to the desired developmental time point by use of an incubator. As the embryo develops 
ex-ovo, no harm comes to the mother, making it an excellent choice for ethical reasons. Embryos within 
the eggs can be manipulated in-ovo, or they can be removed and grown ex-ovo, allowing development 
to be properly monitored. 
 
  In the early 2000s, scientific advances have made the chick an even more attractive model for studying 
embryo development; the whole chicken genome was properly sequenced and expression vectors were 
optimised for different applications. For example, vectors were developed for misexpression 
experiments that could be targeted to a group of cells using electroporation techniques (Yaneza et al., 
2002, Nakamura and Funahashi, 2001). This approach allows for quick gain of function experiments, 
with control over both the positioning and timing of the gene of interest. For loss of function 
experiments, dominant negative constructs, or fluorescein-labelled morpholino could be introduced 
(Sheng et al., 2003, Nakamura et al., 2004). This approach gave advantage over the previous popular 
Xenopus embryos, due to the spatial precision and developmental time point the morpholino or 
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Aims  
  Enhancers are clearly important in genetic regulation and embryonic differentiation. For example, the 
enhancer that controls Myf5 is essential, as mutations within this region result in a lack of muscle 
differentiation (Daubas and Buckingham, 2013). Mef2 binds to many enhancer regions of muscle 
development genes, allowing for their activation and transcription. The aim of this project was to 
elucidate the control mechanisms that regulate myogenesis, chondrogenesis and the development of 
tendons, by identifying novel enhancers that are active in somites that may regulate genes involved in 
the development of the musculoskeletal system. To identify the likely candidate enhancer regions, the 
ATAC-sequencing dataset already established in the Münsterberg laboratory was utilised to identify 
regions of open chromatin near to genes of interest that may contain regulatory cis-elements. These are 
cloned into a fluorescent reporter construct, and then injected into developing embryos and screened 
for reporter activity.    
Chapter 2: Methods and Materials 
2.1 ATAC sequencing and analysis 
  Previously generated ATAC-sequencing datasets were utilised to find putative enhancer regions. 
ATAC-sequencing was performed as described previously (Buenrosto et al., 2015). The ATAC libraries 
were made from pre-segmented mesoderm and somites that had been removed from a stage 14 embryo 
at one of three defined stages of differentiation: epithelial somite, maturing somite and differentiating 
somite (Fig.4). The sequencing reads were mapped to the Gallus gallus genome and can be viewed 
using the UCSC genome browser. Leighton Folkes developed the bioinformatics pipeline, including a 
differential peak-calling algorithm. Higher levels of sequence reads indicated areas of high 
transposability, denoting regions of open chromatin. Putative enhancer regions were picked based on 
their sequence homology with other vertebrates, which can be viewed on UCSC genome browser. 
2.2 RNA and ATAC sequencing/transcriptomics and analysis 
   The Münsterberg lab had previously generated both ATAC-sequencing and RNA-sequencing data 
sets. Both data sets were generated from dissected pre-somitic mesoderm (PSM), epithelial somite 
(ES), maturing somite (MS) and differentiated somite (DS) from a HH14 embryo. The sequencing 
was repeated in triplicate (Mok et al., 2021).   
To utilise this data set to identify genes involved with early muscle differentiation in the somite, the 
expression pattern of MyoG was identified (see figure 2.1 below), and genes that shared a similar 
expression pattern were analysed. As MyoG is active in differentiating somites, due to the role it plays 
in early muscle differentiation, its expression profile is useful to find other genes involved in the same 
pathway. Generally, the other genes identified showed lower levels of RNA expression in the PSM 
and higher levels of RNA expression in the differentiated somite (fig.3.6 and 3.7). Genes involved 
with tendon and cartilage expression were first identified from literature research. The RNA 
sequencing was then utilised to pick genes from the literature search that showed high levels of RNA 
expression in the differentiated somites compared to the PSM.  
  The genes chosen from the RNA-sequencing dataset and introduced in 1.5 were viewed in the UCSC 
Chicken Genome Browser (2015), with the ATAC-sequencing data mapped to it (Mok et al., 2021). 
The ATAC-sequencing dataset had also been generated by dissecting out individual regions of PSM, 
singular epithelial, maturing and differentiated somites and performing the ATAC-sequencing protocol 
discussed in 1.53. Peaks in the ATAC-sequencing data set correspond to accessible and bound regions 
of chromatin and were therefore identified as candidate enhancer regions (fig.3.6 and 3.7). In addition, 
sequence conservation between species was considered when picking candidate enhancer regions. An 
example is shown in figure 3.8 below for the ALX1 locus, viewed in the USCS chicken genome 
browser. Some regions were also picked based on the presence of HK27ac3 histone modification 
present in humans as this mark is involved with active cis-regulatory regions.   
 
 





Figure 2.1: The RNA sequencing was performed on dissected pre-somitic mesoderm (PSM), epithelial somite (ES), maturing 
somite (MS) and differentiated somite (DS). A) The expression profile for MyoG, counted in counted in log2 counts per 
million plus 1. This shows high levels of expression of MyoG in the differentiated somite B) The expression levels of genes 
identified as the myotome cluster K-means clustering analysis on the RNA sequencing. Some genes are labelled to identify 
the key transcription factors found in the myotome. (Mok et al., 2021). 
2.3 Visualising Gene Expression  
  Patterns of gene expression were detected using whole-mount in-situ hybridisations (WISH). This 
procedure elucidates the spatial and temporal regulation of gene expression in embryos, by visualising 
mRNA expression. Probes were designed for mRNA transcripts produced by genes found to be of 
interest from the analysis of the RNA-sequencing dataset. 
2.3.1 Probe Preparation and Whole Mount in situ Hybridisation 
  Digoxigenin labelled antisense probes were synthesised by first designing primers that were specific 
to the cDNA of the gene of interest. Primer design used the NCBI primer design tool (Ye et al., 2012), 
and some of the parameters considered when choosing primers included a GC content of less than 60%, 
and primer melting temperatures between 57°C and 63°C, with an optimum of 60°C. A full list of 
primers can be found in table SI tables 1 and 2.  
 Template cDNA was synthesised from total RNA from a HH14 chick embryo. Fragments between 
500bp and 1.5kb in length for the gene of interest were amplified (KAPA LongRange, Sigma-Aldrich; 
Cat no./ID LRHSRMKB) and purified (QIAquick PCR Purification kit; Cat No./ID: 28104). The 
derived PCR products were cloned into the pGEM-T vector (Promega; Cat no./ID A1360), which 
contains an ampicillin resistance gene (AmpR), a lacZ locus and Sp6, T7 and M13 priming sites (see 
figure 2.2). The ligation product was used to transform competent E. coli bacteria (Strain: DH5α). 
Transformants were plated onto selective LB agar plates and colonies were grown overnight. LB plates 
were spread with x-gal, to allow for selection of white colonies. Positive colonies were grown in 5 ml 
LB liquid culture overnight at 37°C. DNA was extracted from cultures using a QIAGEN mini-prep kit 
(Cat No./ID 27104), and 10ng/µl of DNA was sequenced at Eurofin Genomics. Returned samples with 
correct sequencing were checked for orientation and PCR amplified with M13 primers. Resulting PCR 
products were used to synthesise anti-sense RNA probed by in-vitro transcription using T7 and SP6 
RNA polymerases. The probes were then purified using GE Healthcare Illustra probequant G-50 micro 
columns (cytiva; product code 28903408).  
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Figure 2.2: A vector map of the pGEM-T vector, which contains a LacZ site with multiple restriction sites for cloning of 
constructs, as well as an Ampicillin resistance gene. Image taken from Promega (https://www.promega.co.uk/). 
Chick embryos at the desired stages were harvested and fixed in 4% PFA and stored for up to six 
months. Whole mount RNA in-situ hybridisations were performed as described previously (Nieto and 
Wilkinson., 1996). Post hybridization washes were carried out using MABT (maleic acid buffer 
containing 0.1% Tween-20) and target-specific probe binding was visualized using NBT/BCIP (nitro-
blue tetrazolium chloride/5-bromo-4-chloro-3’-indolylphosphate p-toluidine salt) as the colour marker. 
The time to develop the colour reaction varied with each probe, from 2 hours to several days.  
2.4 Histological Sectioning and Imaging 
  Fixed embryos were immersed in 30% sucrose in PBS overnight at 4°C before embedding in OCT 
Embedding matrix (CellpathTM, Fisher Scientific; Cat no./ID 1521277). Embedded samples were 
mounted in a cryostat and sectioned into 20µm slices. These were then mounted onto microscope slides. 
Cryosections were then washed (3x 10 min washes in dH2O), before applying a slide cover using 
hydromount. 
2.5 Cloning Plasmid constructs 
  Enhancer regions identified by ATAC-sequencing analyses were PCR amplified (KAPA LongRange, 
Sigma-Aldrich; Cat no./ID LRHSRMKB) from chicken genomic DNA (PureLink gDNA mini kit, 
Invitrogen; Cat no./ID K1820-00). Golden Gate based cloning of putative enhancer regions into a ptk- 
Citrine vector, which contains a lacZ locus (see figure 2.3) was then performed.  Plasmid safe reactions 
were performed as this selectively hydrolyses linear double stranded DNA, removing any un-ligated 
plasmids and contaminating DNA. This reaction was performed by combining 10.25µl of the previous 
BsmBI reaction to 1.25µl plasmid safe buffer, 0.5µl 25mM ATP and 0.5µl plasmid safe enzyme. 
Plasmid constructs were then transformed into competent DH5-α E. coli cells, which were grown in 
5ml liquid LB culture at 37°C. PCRs on ampicillin resistant colonies were performed to ensure the 
inserted sequence was the correct size. Plasmid DNA was extracted using a QIAGEN plasmid maxi 
prep kit (Cat no./ID 12162), ready for injection into embryos.  
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Figure 2.3: The ptk-Citrine vector map. This contains the ampr gene for initial selection of plasmids, a TK minimal promoter, 
a lacZ operon and the citrine gene. Putative enhancer regions would be inserted into the plasmid between the minimal 
promoter and the citrine reported gene, disrupting the lacZ operon. 
2.6 Easy Culture 
  To culture gastrulating chicken embryos, early chick (EC) culture methods were used (Chapman et 
al., 2001). Fertilised chicken eggs from Henry Stewart & Co. Ltd were incubated for 20-22 hours at 
37°C.  Egg contents were deposited into a petri-dish, and an area of albumen was cleared from around 
the embryo. A ring of filter paper with a hole in the centre was positioned over the embryo and yolk 
and allowed to attach to the vitelline membranes, framing the embryo. The embryo was then attached 
under tension to the filter ring and, after cutting around the outside of the filter ring, can be removed 
from the yolk. The embryo is then washed, inverted, and placed ventral-side up on 30mm petri-dishes 
containing an agar-albumen mixture as described by Chapman (Chapman et al., 2001). Embryos were 
then grown at 37°C to the desired stage of development. 
2.7 Plasmid injections and electroporation 
HH3+ chick embryos harvested via EC method as described were transferred ventral side up to an 
electroporation chamber containing Ringer's Buffer and a 2mm2 platinum-based electrode. Using a 
pulled glass capillary and a microinjector, embryos were injected with the candidate putative enhancer 
reporter plasmid (1μg/μl) in 10% injecting dye (Fast Green FCF, Sigma-Aldrich; Cat no./ IDF7252) 
throughout the embryo proper, between the primitive streak and the epiblast. Electroporation was then 
performed using a 2mm2 positive electrode (cathode) which was placed above the embryo in the Ringers 
buffer solution. Five pulses (5V for 50ms at 100ms intervals) were then applied using a square wave 
electroporator. Embryos were returned to the agar albumen petri-dishes and grown for 20-22 hours at 
37°C. They were then observed under a fluorescent stereomicroscope at stages HH10-HH14. Embryos 
that displayed fluorescent reporter activity were fixed in freshly thawed 4% paraformaldehyde (PFA) 
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and stored at 4°C for up to 4 weeks. Table 2 in the supplementary information (SI) shows all the putative 
enhancer regions, if they were successfully cloned into the reporter construct, the number of injections, 
if these were successful or not and if a positive control was used. pCIGcherry was co-injected with the 
fluorescent reporter construct, and MEOX1 enhancer construct was injected into different embryos but 
at the same time and under the same conditions as the investigated construct. SI Table 1 shows the 
primers that successfully amplified candidate enhancer regions which were then cloned into a reporter 
construct.  
2.8 Summary of Enhancer discovery Pipeline 
 
Figure 2.4: A diagram showing the experimental pipeline. A) ATAC-sequencing can identify regions of open DNA, that are 
devoid of nucleosomes and histones, as shown in B. The enhancer region is cloned into a fluorescent reporter plasmid vector 
(C), transformed into E. coli, to amplify the plasmid DNA (D). Purified plasmid DNA is electroporated into HH3+ chicken 
embryos (E), which are cultured using easy-culture methods and cultured in agar-albumen dishes (Chapman et al., 2001). The 
embryos are left to grow for 24hours in a 37°C incubator before being visualized under a confocal microscope with UV light 
(F), to look for expression of the GFP protein, indicating that the enhancer is also expressed in those regions. 
 
2.9 Foxo-1 sequence conservation 
The Foxo1 whole mount in-situ hybridisation showed specific expression signal in the somites (see 
section 3.1). As this was a novel discovery, with Foxo1 not previously being described as present in 
the somites at early stages, it was further investigated for sequence conservation between species, to 
understand if this protein is fundamental in most organisms. Firstly, a protein sequence alignment was 
performed using Aliview software (Larson., 2014) to identify regions of homology or regions where 
the sequence is different between species (see figure 3.12). From this protein alignment, a 
phylogenetic tree for this gene could be produced, using the MEGAX software (fig. 3.13).  
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Chapter 3: Results 
 
3.1 Whole Mount in-situ Hybridisation Results  
  Gene expression patterns were visualised for the genes chosen from RNA-sequencing dataset to 
ensure they were expressed in the somites during chick development. Probes were designed for the 
genes Foxo1, Scx, Pax1, Tn-C, Mkx, Alx-1 and UncX (see SI Table 1 for a list of primer pairs). 
However, only the Foxo1, Scx and Pax1 probes were completely synthesised and showed a specific 
signal, restricted to the somites. As there is no other characterisation of Foxo1 in chicken embryos, in 
either GEISHA (A database of expression patterns for chick embryos) or in any other literature, a 
stage series of whole mount in-situ hybridisations for this gene was performed (see figure 3.1-3.3), to 
observe the spatiotemporal patterns of Foxo1 gene expression throughout development. Sections were 




Figure 3.1: Whole mount In-Situ hybridizations showing patterns of mRNA expression of the Foxo-1 gene throughout 
development; A) HH.4, C) HH.6, E) HH.8 G) HH.10. B, D, F and H are close ups of the regions depicted in the boxes in A, 
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Figure 3.2: Whole mount In-Situ hybridizations showing patterns of mRNA expression of the FOXO-1 gene throughout chicken 
development; A) A HH12 embryo, C) A HH14 embryo, E) A HH15 embryo and G) a HH17 embryo. B, D and F show close 




Figure 3.3: Whole mount In-Situ hybridizations showing patterns of mRNA expression of the FOXO-1 gene throughout 


















Figure 3.4: Cryostat sectioning of a HH 14 embryo into 20μm sections. A) HH14 embryo that is sectioned. B) A close up of 
the region in the box shown in A, and where the corresponding sections were taken from. I-VI) 20UM sections taken at 10x 
magnification. For abbreviations, see SI 1.1.  
 
 
Figure 3.5: Whole mount in -situ hybridisations on HH14 embryos for A) PAX-1 and B) SCX. 
 
3.2 ATAC sequencing regions and RNA-sequencing 
The ATAC-sequencing was mapped to GalGal 5 on the UCSC genome browser. Figs. 3.6 and 3.7 
show the locus of the gene of interest with mapped ATAC peaks below. The four different stages of 
somite differentiation are represented by different colours: from the PSM track in green, the ES track 
in blue, MS track in yellow, and the DS track in red. The expression data from the RNA-sequencing is 
shown alongside the corresponding gene track.  Regions chosen as putative enhancer regions are 
highlighted in blue. A list of primer pairs that amplified these chosen regions can be found in the 
supplementary information (Table 1).    
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Figure 3.6: The ATAC-sequencing dataset mapped to the UCSC chicken genome browser (2015) for genes involved with 
muscle development. Peaks chosen for subsequent amplification and cloning are highlighted in blue. The different tracks 
represent different stages of somite development; DS is the most differentiate somite, MS is a maturing somite, ES is an 
epithelial somite, and PSM is the presomitic mesoderm. Each image shows the ATAC-sequencing tracks and regions chosen 
as candidate enhancers for, A) MEOX2, B) FOXO1, C) UNCX, D) KLHL31 and E) ALX1. Above each peak is a unique 
identifying number for each candidate enhancer region. Alongside the ATAC-sequencing tracks are the gene expression 
levels for the corresponding gene, based on RNA sequencing, counted in log2 counts per million plus 1. 






Figure 3.7: The ATAC-sequencing dataset mapped to the UCSC chicken genome browser (2015) for genes involved with 
cartilage and tendon development. Peaks chosen for subsequent amplification and cloning are highlighted in blue. The 
different tracks represent different stages of somite de development; DS is the most differentiate somite, MS is a maturing 
somite, ES is an epithelial somite, and PSM is the presomitic mesoderm. Each image shows the ATAC-sequencing tracks and 
regions chosen as candidate enhancers for, A) Mxk, B) Scx, C) TNC D) Pax1 and E) Pax9. Above each peak is a unique 
identifying number for each candidate enhancer region. Alongside the ATAC-sequencing tracks are the gene expression 
levels for the corresponding gene, based on RNA sequencing, counted in log2 counts per million plus 1. 




Figure 3.8: How putative enhancer regions were picked. A) Using the ATAC-sequencing data set which visualises open 
regions of chromatin as a peak and is mapped to the chicken UCSC genome browser galGal5 version. B) Using sequence 
conservation with other species, in the UCSC genome browser galGal6 version. there are tracks for conservation with 
turkey (Meleagris gallopavo), Chinese alligator (Alligator sinensis), human (Homo sapiens), mouse (Mus musculus), 
zebrafish (Danio Rerio), and Frog (Xenopus tropicalis). All candidate enhancer regions are highlighted in blue, using the 
ALX1 locus as an example.  
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3.3 Visualising the Fluorescent Reporter Constructs  
  HH3+ embryos were injected around the primitive streak and above the node with a GFP reporter 
construct that contained the putative enhancer region.  
3.3.1 MEOX1 Enhancer 
  To test electroporation into HH3+ embryos positive controls were used.  GFP and Cherry reporter 
constructs were injected and electroporated, to test for electroporation efficiency and targeting (see 
supplementary figure S.2 for examples). Another positive control was a MEOX1 enhancer reporter 
construct, which had been previously generated in the lab by the same pipeline discussed in the methods 
section. This had been shown to be active in somites (Mok et al., 2021). This construct was injected 
and electroporated and served as a control for electroporation efficiency. Figure 3.9 shows reporter 
enhancer activity in the somite of a HH10 embryo (N=15).  
 
Figure 3.9: A HH10 embryo (ventral side) after injection and electroporation at HH4 with the Meox1 enhancer region 
previously described by the Münsterberg lab, showing reporter activity in the somites. 
 
 
3.3.2 Foxo1 Enhancer  
For the candidate regulatory elements associated with genes involved in somite patterning, only one 
of the putative enhancer regions cloned showed fluorescent reporter activity. This enhancer region 
was associated with the Foxo1 gene and is enh145 (see figure 3.6). Fluorescence was detected in the 
blood islands and pharyngeal mesoderm of a stage 10 embryo. This result was identified in three 
separate embryos form white eggs, and one from a brown egg. These embryos showed a different 
signal with the same fluorescent reporter, with signal in the inter-somitic blood vessels and at a later 
stage in the dorsal aorta (fig.3.10 and 3.11).  
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Figure 3.10: A HH10 embryo displaying fluorescent reporter activity with the putative Foxo1 enhancer reporter construct. 
Fluorescent reporter activity is shown in the blood islands and pharyngeal arches. Different reporter activity was visualised 
in brown eggs (ABC) and white eggs (DEF). A, D) Brightfield image B,E Citrine image and C,F) a combination of both 
brightfield and citrine images. 
 
 





Figure 3.11: HH10 embryo ventral side cultivated from a brown egg and injected with the foxo-1 enhancer reporter 
construct. A) Citrine and brightfield image of the embryo at HH10. B) A close up of A, showing signal in the inter-somitic 
vessels, and the dorsal aorta.  
3.4 Foxo-1 Sequence conservation  
The sequence comparison of the Foxo1 chick cDNA indicated that most regions of the Foxo1 gene is 
conserved between human, mouse, and zebrafish (fig. 3.12).  Phylogenetic tree analyses were then 
performed using MEGAX for the foxo1 gene in different species; chicken (Gallus gallus), duck (Anas 
Platyrhynchos), the green anole lizard (Anolis carolinesis), human (Homo sapiens), mouse (Mus 
musculus) Frog (Xenopus tropicalis), zebrafish (Danio rerio), Caenorhabditis elegans and Phallusia 
mammilata, a marine tunicate. Further analysis of the domains within the Foxo1 protein revealed the 
presence of a Forkhead DNA binding domain, a KIX binding domain and a TAD binding domain (fig. 
3.14) 
As the chick genome is poorly annotated, there was a possibility that the Foxo1 gene was incorrectly 
assigned. The cloned region of cDNA for Foxo1 DIG RNA probe could have been a segment of a 
different gene. To minimise this risk, the flanking regions around Foxo1 were examined and 
compared with other species. Genes such as COG6, SLC25A1, MRPS31 and DCLK1 were observed in 
the flanking regions of Foxo1 in the chicken genome. These genes were then searched for in other 
species with genomes that have been thoroughly sequenced, such as human and mouse. To obtain a 
more complete overview of blocks of synteny throughout evolutionary time, genomicus was used to 
produce a schematic (fig.3.15). Foxo1 is the central gene represented by a green block, and the other 
coloured blocks represent other genes that are near the Foxo1 locus in other species. 




Figure 3.12: Protein alignment of the Foxo1 orthologues in the Chicken (Gallus Gallus), Human (Homo sapiens), Mouse 
(Mus musculus) and Zebrafish (Danio Rerio). The highlighted amino acids are different between species. 
 
Figure 3.13: A phylogenetic tree for the Foxo1 gene in different vertebrae was inferred by using the Maximum Likelihood 
method and Jukes-Cantor models, displayed on a bifurcating tree. The bootstrap consensus tree inferred from 200 
replicates, and the percentage of percentage of replicate trees in which the associated taxa clustered together in the 
bootstrap test are shown next to the branches. Neighbour-Join and BioNJ algorithms were applied to a matrix of pairwise 
distances estimated using the Maximum Composite Likelihood (MCL) approach, and then selecting the topology with 
superior log likelihood value. Evolutionary analyses were conducted in MEGA X (Kumar.,2018). 
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Figure 3.14: A screenshot of the conserved domains found within the FOXO1 gene, using the NCBI Conserved Domain tool. 
FOXO1 contains a Forkhead DNA binding domain (in green), a KIX binding domain (in pink) and a TAD binding domain 
(in blue). 
 
Figure 3.15: A schematic generated in Genomicus (https://www.genomicus.biologie.ens.fr/genomicus-98.01/cgi-
bin/search.pl) depict regions of synteny around the Foxo1 gene within different species. Foxo1 is depicted by the light green 
box in the centre with a line. Other coloured blocks represent different genes. The other organisms analysed included other 
birds; the Turkey, Zebra finch and African ostrich. Reptiles included the Australian saltwater crocodile, the common wall 
lizard and lizard. Mammals included in the analysis included pug, cow, dog, car, horse, rat, mouse and human. The amphibian 
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3.5 NKX 2.5 enhancer  
Whilst cloning constructs related to this project, one other putative enhancer region from an ongoing 
project was also cloned into their reporter vector, injected and electroporated using the same pipeline 
as discussed in the methods. This displayed a positive result; Nkx2.5 which is an early cardiac marker, 
displayed signal in the pharyngeal mesoderm and first heart field mesoderm in a HH10 embryo 
(Fig.3.16) (N=6).  
 
 
Figure 3.16: A HH15 embryo (ventral side) after injection and electroporation with a candidate Nkx2.5 enhancer reporter 
construct, showing fluorescent reporter activity in at the bottom of the primitive streak and in the pharyngeal mesoderm. 
 
3.6 TOMO-sequencing whole mount in-situs  
  An ongoing project in the lab involves using the relatively new technique TOMO-sequencing to 
identify novel genes (Fruse et al., 2016). TOMO-seq provides genome-wide expression data with 
spatial information. Dr. G. Mok preformed the TOMO-sequencing protocol on a HH14 chick embryo, 
and sequencing was performed along the embryonic axis. The genes identified from the TOMO-
sequencing dataset for further analysis by WISHs were TNFRSF14, ARIM1, AHNAK, Wnt5a, HBM, 
SZL, LRIG3 and NES. However, only the probes for Wnt5a, ARIM1, LRIG3 and HBM were 
successful in hybridising to mRNA transcript during WISH. A list of primer pairs that were used to 
generate the probes can be found in the supplementary information (Table 3). The Wnt5a expression 
pattern was specific to the tail bud of embryos, ARIM1 expression was restricted to the posterior 
neural tube, HMB expression was found in the inter-somitic blood vessels and dorsal aorta and 
LRIG3 expression was refined to the posterior epithelial somites and PSM (fig. 3.17).   
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Figure 3.17: Whole mount in-situ hybridisations for genes chosen from the Tomo-sequencing dataset. A) Wnt5a, B) ARIM1, 
C) HBM, and D) LRIG3. E, F, G and H are all close ups of the regions of expression for Wnt51, ARIM1, HBM and LRIG3 
respectively. 
 
3.7 Single Cell RNA sequencing  
To aid Dr. Gi Fay Mok on work with single cell RNA sequencing data taken from somites, other 
genes were chosen from a single-cell RNA-sequencing dataset, which showed differential expression 
in differentiated somites. The inclusive list of genes chosen, and primer pairs used to generate probes 
can be found in the supplementary information (Table 4). Whole-mount in-situ hybridisations were 
performed for these genes, with only RAPSN, UNC45b and LAMA2 showing any specific expression 
in the somites. (fig.3.18). In-situs were also performed for the gene NPAS4l, to aid Dr. Gi Fay Mok on 
work in the haematopoietic lineage (Fig.S1). The NPAS4l gene expression was found in the blood 
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Figure 3.18: Whole mount in-situ hybridisations for genes identified by the Single Cell RNA-sequencing analysis. A) 
LAMA2, B) RAPSN and C) UNC45b. 
4 Discussion 
  Previously, the Münsterberg lab has been successful in identifying enhancers associated with 
Meox1, Tal1, and Paraxis, using the ATAC-sequencing dataset, which was performed on somites of 
varying levels of differentiation (Mok et al., 2021). In this study, the aim was to use this same 
pipeline to identify a range of enhancers associated with genes that are characteristic of most cell 
lineages within the somite. This study looked at 29 different putative enhancers regions, however, 
only one was identified as a potential enhancer, which was associated with the Foxo1 gene. In-situ 
hybridisations were also performed on genes associated with the chosen enhancer regions, and an 
expression profile for the Foxo-1 gene was generated.  
4.1 RNA-sequencing 
The RNA-sequencing of the genes stated in 1.6 indicated high levels of expression in somites. Alx1, 
Klhl31, UncX, and Meox2 showed similar expression profiles to genes such as Meox1 and MyoG, as 
they had lower levels of expression in the PSM and higher levels of expression in the fully 
differentiated somite. This suggests these genes are involved with muscle differentiation, as the 
myotome lineage is fully formed in the differentiated somite. Pax1 and Pax9, the key genetic markers 
of the sclerotome also showed the same expression pattern as the myotome genes. Pax1 and Pax9 are 
required for the proliferation of sclerotomal cells, so it is expected that these genes are highly 
expressed in later stage somites, as well as the expected epithelial and maturing somite stages. The 
genes associated with syndetome formation (Mkx, Scx and TnC) all showed ubiquitous expression 
throughout all stages of somite development. The exception to this is TnC, which showed slightly 
lower levels of expression in PSM and higher levels in the differentiated somite. However, it is 
interesting that these genes were present in the RNA sequencing of a HH14 embryo, as previous 
research has suggested that genes involved with tendon differentiation are not expressed until roughly 
HH18 (see section 4.11 for more details). This would suggest that cells of a syndetome lineage are 
perhaps specified earlier than previously thought, and further research into this could be interesting.  
 
4.2 ATAC-sequencing  
  Physical access to DNA relies on chromatin accessibility, which is controlled by highly dynamic 
chromatin remodelling, and plays an essential role in establishing cellular identity. ATAC-sequencing 
was used as it identifies these regions of open chromatin. If a region of chromatin is accessible, it 
allows TFs to associate with their binding sites. ATAC-sequencing is therefore a good indication of if 
an enhancer is present in the chicken genome; however, not all open regions of DNA will be 
associated with an enhancer region. Of the ten regions successfully cloned into their reporter 
constructs, only one showed fluorescent reporter activity (see SI Table 2 for an overview of all 
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enhancer reporter constructs, and which were successfully generated). Whilst a region of open 
chromatin could be associated with an enhancer, they are also identified in other various roles, such as 
DNA replication (Rampakakis, et al., 2009), nuclear organisation (Biddie et al., 2010), and other 
regulatory regions such as insulators or silencers (Kolovos et al., 2012).  For example, the origin 
recognition complex, a transcription factor that is essential for the initiation of DNA replication, has 
been shown to bind to regions depleted of nucleosomes (open regions of chromatin), that have no 
clear sequence motifs (MacAlpine et al., 2009).  The chromatin landscape is highly dynamic, and 
often changes to accommodate the replication process. It is likely that the peaks selected as putative 
enhancers are open regions of chromatin associated with other regulatory elements or aid in chromatin 
dynamics, as most putative enhancer constructs were co-injected with a cherry reporter (SI Table 2), 
which demonstrates the efficiency of injecting and electroporating as targeted cells fluoresces red. 
This co-injecting shows that all the constructs were successfully injected and electroporated, however, 
only one enhancer construct showed green fluorescence in embryos.  
  Other regions of open DNA can include smaller regions that contain binding sites for chromatin 
remodelling complexes or CTCF. These regions can act to open nearby chromatin which could 
contain a regulatory element (Clapier, et al., 2017). Chromatin is highly dynamic and can also 
undergo looping to bring a region of DNA into proximity with another (see section 1.53). While a 
region of open DNA may not be a cis-regulatory element, it could be playing an important role in the 
chromatin architecture and nuclear organisation (Biddie et al., 2010). These regions of non-coding 
DNA with binding sites for chromatin remodelling complexes such as ISWI and CHD or CTCF 
would be accessible and could have been selected as a putative enhancer region. If this were the case, 
and putative enhancer regions selected were binding sites for chromatin remodelling, they would 
show no reporter fluorescence.  
  However, it is also possible that the selected peaks were enhancer regions which were not activated 
until much later in development. This is most likely the case with putative enhancer regions 
associated with tendon and cartilage development, such as Tn-c and Mkx. These genes are associated 
with later stages of tendon development, and transcription of these genes may not occur before HH12, 
where survival rates for cultured manipulated embryos drops. The RNA-sequencing suggests these 
genes are present in HH14 embryos, and to fully test these putative enhancer regions, it would be 
necessary for injected embryos to survive past HH12 until roughly HH18. One way to overcome this 
issue would be to perform in-ovo electroporation and injections, as previously described by Scaal et 
al., 2004, as well as other culture methods such as the modified Cornish Pasty (MC) method 
(described below in 5.1).  
There was a low efficiency of cloning the enhancers regions into their constructs. Of the twenty-nine 
peaks selected for cloning, only ten of these were successfully cloned into the reporter construct and 
electroporated (See SI table 2). The failed cloning attempts were unsuccessful for several reasons. Six 
of these showed incorrect sequencing after cloning into their constructs. This indicates that the 
primers are non-specific in their binding and are amplifying regions of genomic DNA that are the 
similar in size to the desired regions. Eleven of these regions were not amplified from gDNA with 
primers; these primer pairs may have formed hairpin loops and were unable to amplify gDNA. Two 
were unsuccessfully transformed into the citrine reporter plasmid with multiple attempts. These low 
rates of cloning could potentially be solved with more care in the design of primers, checking for 
binding to unintended targets. 
4.3 Foxo1 Expression Pattern  
  The Foxo1 whole mount in-situs performed characterised a novel expression pattern in chicken 
embryos. This project shows for the first time the expression pattern of Foxo1 throughout different 
stages of chicken development, from HH4 to HH25. Embryos that were used in whole mount in-situ 
hybridisations with a Foxo1 anti-Dig mRNA probe showed signal above the node in HH4 and then a 
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restricted expression pattern in the somites throughout development. Sectioning of HH14 embryos 
revealed expression of Foxo1 throughout the epithelial somite. In more differentiated somites an 
interesting pattern emerged. Somite sections showed signal in the myotome, this alternated with 
sections that showed signal in the sclerotome. The expression pattern observed suggested that 
expression is restricted to the sclerotome in the anterior part of the somite, but in the posterior region 
expression is refined to the myotome, and the most anterior section showed no expression of Foxo1. 
  During the sectioning of HH14 embryos that had undergone a whole mount in-situ hybridisation 
with the Foxo1 probe, there were sections of somite without Foxo1 mRNA expression. This would 
indicate a rostral-caudal patterning of Foxo-1 expression, similar to the expression patterns seen in 
genes such as TBX18 and UNCX, which show signal restricted to either the rostral or caudal halves 
of the somite (Sánchez and Sánchez, 2013). This expression pattern could indicate a role for Foxo1 in 
the segmentation of somites. This specific pattern has not previously been recorded in other 
organisms. Studies that identify Foxo1 expression in mouse embryos depict it in the blood vessels, 
heart, and branchial arches of younger stage embryos. In older stage embryos, Foxo1 expression is 
restricted to somites and the expression in blood vessels is no longer detected (Villarejo-Balcells et 
al., 2011). To confirm the Foxo1 expression across the rostral-caudal extent of somites, more 
sectioning of both younger and older stage embryos is required.  
  Foxo1 expression in the myotome is not surprising as Foxo1 plays a role in muscle differentiation. 
Previous studies have shown the phosphatidylinositol 3-kinase (PI3K)/Akt and Rho/ROCK signalling 
pathways are involved in mediating Foxo1 transcriptional activity through phosphorylation of Foxo1 
to exclude the protein from the nucleus (Hribal et al., 2003, Matsuzaki et al., 2003). Other studies 
support the role of Foxo1 as a negative regulator of early myoblast differentiation. For example, Wu 
et al., (2008) demonstrated a regulatory loop between Foxo1 and mTOR, an important regulator in the 
differentiation of C2C12 myoblasts, which upregulates the expression of IGF-II (Erbay et al., 2003). 
IGF-II is a critical regulator of skeletal muscle differentiation and adult muscle regeneration (Florini 
et al., 1991) and is an upstream signal of PI3K/Akt pathways (fig.4.1) (Stitt et al., 2004, Jiao et al., 
2012). Foxo1 reduces the production of IGF-II and therefore initiates a negative feedback loop of 
myogenesis. The IGF-II-PI3K/Akt-Foxo1-mTOR regulatory loop seems to play a critical role in 
skeletal muscle differentiation, and deserves further study, to increase our understanding of skeletal 
muscle genetic regulation.  
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Figure 4.1: Foxo1 is regulated through retention in the cytoplasm by phosphorylation from upstream signals including IGFs 
and is mediated through the PI3K-Akt pathway. Downstream targets of Foxo1 include myostatin, MyoD, mTOR and 
MEF2C. Early myoblast differentiation is negatively regulated through inhibition of MyoD, MEF2C and mTOR, and 
upregulation of myostatin by Foxo1. Despite negatively regulating early myoblast differentiation, Foxo1 is required for 
myoblast terminal differentiation fusion into myotubes, however, the molecular mechanism regulating this is still unknown.   
  Foxo1 also represses myogenic differentiation through stimulation of myostatin and repression of 
MyoD (Allen et al., 2007, Liu et al., 2007). Myostatin has been reported as a potent negative regulator 
of myoblast proliferation and loss of function of myostatin leads to muscle overgrowth, as seen in 
Belgian Blue cattle and Texel sheep (McPherron, et al.,1997). Previous studies have demonstrated 
myostatin is a downstream signal of Foxo1 signalling, which can bind directly to the myostatin 
promoter region and increase myostatin mRNA expression (Allen et al., 2007). These studies suggest 
that Foxo1 could be repressing myogenic differentiation by stimulating expression of myostatin. The 
Foxo1 fusion proteins Pax3/Foxo1 and Pax7/Foxo1 can also interfere with MyoD transcriptional 
activity, which represses downstream targets of MyoD (Calhabeu et al., 2012). These two fusion 
proteins inhibit transcriptional activation of MyoD, and transgenic Pax3/Foxo1 in mice can disrupt 
normal myogenesis in somites (Finckenstein et al., 2006).   
  Foxo-1 expression in the myotome would suggest a role for Foxo1 in delaying myogenesis, 
preventing early myoblast specification. Whilst at these stages the myogenic differentiation 
programme would have already begun to produce committed cells committed to a skeletal muscle 
fate, the inhibitory action of Foxo1 would prevent too many cells from committing. This allows for 
the correct number of cells to adopt a muscle fate, without either the consequences of too many 
myogenic cells (hypertrophy, and potentially cancerous) or too few.  
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  However, several other reports suggest that Foxo1 is necessary for myoblast terminal differentiation, 
and regulates muscle fibre type specification (Yuan et al., 2010). The expression pattern of Foxo1 in 
the stage 25 embryo could be in the primary myofibers in the somites, but further sectioning 
experiments would need to be performed to validate this theory.  
  This report also found expression of Foxo1 in the sclerotome (fig.3.5). This expression could be a 
way of maintaining the sclerotome as a region of cells not committed to the myogenic fate, with 
Foxo1 acting as a repressor of muscle differentiation. However, a recent study has described Foxo1 as 
a positive regulator of chondrogenic differentiation (Kurakazu et al., 2019), as it’s upregulated by 
TGFβ, a growth factor that plays a key role in chondrogenic differentiation. Foxo1 expression 
increases with chondrogenic differentiation, while inhibition of Foxo1 results in supressed expression 
of collagen differentiation markers such as Col2a1 and Acan, along with repressed chondrogenic 
differentiation (Kurakazu et al., 2019). Previous studies have demonstrated the binding of Foxo1 to 
the Sox9 promoter, increasing expression (van Gastel et al., 2020). As Sox9 initiates chondrogenesis 
(see section 1.24), Foxo1 as one of the transcription factors that initiates it, is clearly important in the 
sclerotome. Therefore, it is unsurprising that Foxo1 transcript is expressed in this somitic 
compartment at this stage.  
4.4: A Novel Foxo1 Enhancer  
  Using the pipeline stated in section 3.7, this project was able to identify the presence of one 
regulatory element, associated with the Foxo1 gene (figures 3.10 and 3.11). This region is conserved 
in human, mouse and Chinese alligator (fig.4.2), and in human, the histone modification H327Ac has 
been detected nearby. When injected into HH4 embryos, the reporter construct that contains the 
putative regulatory region showed signal in the blood islands in HH10 chicken embryos cultured from 
white eggs (n=4), and in the inter-somitic vessels for chicken embryos cultured from brown eggs 
(n=1). In this embryo, that managed to develop to HH12, strong reporter activity can be seen in the 
dorsal aorta. (Fig.3.11) 
 
Figure 4.2: The 2018 genome browser for enhancer 145, highlighted in blue. Below are the tracks for species conservation. 
This putative enhancer region shows sequence conservation with turkey, American alligator, human and mouse. There is no 
sequence information for the zebrafish and X.tropicalis, so it is unknown if this region is conserved in these two species.   
  The reporter signal in the blood islands, dorsal aorta, and inter-somitic blood islands suggests that 
the cis regulatory element is active in endothelial cells and thus could indicate a role for Foxo1 in 
blood vessel development. Previous studies have indicated a crucial role of Foxo1 in blood vessel 
development (Furuyama et al., 2004, Park et al., 2009), with Foxo1 expression identified in the 
vascular system at early stages of development, in mouse whole mount in-situ hybridisation 
experiments. However, from E.11.5 vascular expression is no longer detected in mouse embryos. 
Instead, the gene is expressed in the somites; this could be showing Foxo1 playing a role in the fusion 
of myoblasts and fibre type specification (Villarejo-Balcells, et al., 2011). It has been shown that 
Foxo1 regulates the morphological response of endothelial cells to critical genes involved in 
angiogenesis, such as VEGF (Vascular endothelial growth factor) and angiopoietin-1 (Daly, 2004, 
Zhuang et al., 2013). Mice with Foxo1 knockout are embryonic lethal due to defects in the 
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development of brachial arches and malformation in major vessels of the embryo and yolk sac, 
potentially due to an improper response to VEGF, which is mediated by Foxo1. Younger embryos 
show severe disruption of blood vessel formation (Furuyama et al., 2004, Hosaka et al., 2004). 
Therefore, it is not surprising that an enhancer region associated with Foxo1 would be activating 
Foxo1 in cells of an endothelial lineage. What is surprising is the discrepancy between the enhancer 
reporter pattern and the in-situ pattern; this is discussed further below.  
4.5 Differences in Foxo1 Expression Patterns and Putative Enhancer Patterns: 
  Foxo1 as a transcription factor plays a variety of roles, as discussed above. It has been shown to 
activate enhancers for separate genes, which gives it its diverse functionality. Here, Foxo1 was 
investigated due to its role in skeletal muscle development, as high expression levels were found in 
somites of developing chick embryos. Several candidate enhancers for the Foxo1 gene were cloned 
into fluorescent reporter constructs, one of which displayed reporter activity in the blood islands, 
inter-somitic vessels and the dorsal aorta. However, this expression profile was different to its 
corresponding whole mount in-situ hybridisation, which detected Foxo1 expression in developing 
somites (figures 3.1-3.4). There are several reasons why there is this unexpected discrepancy. It is 
possible that the anti-DIG RNA probe generated for Foxo-1 and used for in-situ hybridisation was 
complementary to a specific isoform of the gene, that is only produced in somites. It is also possible 
that the enhancer cloned was only specific to activating Foxo1 gene expression in blood vessels and 
endothelial cells. These are further discussed below.  
4.6 Protein Isoforms 
  Protein isoforms are sets of similar proteins that originate from a single gene. While some isoforms 
are functionally redundant, several are reported to have unique biological functions (Breitbart, et al., 
1987, Karlsson and Linnarsson, 2017). Isoforms can be formed from the process of alternative 
splicing, post translational modifications, or variable promoter usage (gene isoforms) (for a review see 
Hallegger et al., 2010 and Stamm et al., 2005). Isoforms explain the discrepancy between the large 
number of proteins present in an organism, and the surprisingly small number of protein coding 
genes; each gene has the potential to code for several isoforms, each with a functionally diverse role 
(Breitbart et al., 1987). Alternative RNA splicing is a post transcriptional modification, where the 
final mature mRNA transcript includes or excludes different exons. It was first believed that protein 
isoforms have similar functions to other isoforms from the same gene, whereby they work in the same 
regulatory systems, with slightly differing roles.  However, recent work has shown that most protein 
isoforms share less than 50% of their interactions, behaving like separate proteins rather than slight 
variants of each other (Häfner, 2019). Some may exhibit dominant-negative effects over the other 
isoforms encoded by the same gene, up and down regulate other isoform family members. For 
example, there are two isoforms encoded by the BCL2L1 gene. The longer isoform is involved in 
inhibiting apoptosis, whereas the shorter isoform actively promotes it (Schwerk and Schulze-Osthoff, 
2005). Overall, there are several hundred human genes have been documented to produced 
functionally diverse transcript variants (Kelemen et al., 2013).  
  There are other transcriptional methods that produce different protein isoforms. Gene bodies can 
contain several different promoters within them, resulting in different transcriptional start sites 
throughout the gene producing different length mRNA transcripts (Wang et al., 2016). One recent 
study found that alternative transcription start sites and termination sites are the main cause of isoform 
diversity in human tissues and produced a large dataset of isoforms that are generated in this fashion 
(Reyes and Huber, 2017). The Foxo1 gene could contain other promoters within its gene loci, which 
could interact with different CREs and promote transcription of different parts of the Foxo1 gene, 
producing differing mRNA transcripts. These could have varying roles; one could play a part in the 
formation of blood vessels and the other could play a role in regulating somite patterning and 
differentiation, including myogenesis and chondrogenesis.    
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Programmes such as refseq and enembl genome browsers depict Foxo1 as having one isoform in the 
chick genome. However, the chick genome is poorly annotated, and this may not be correct, as other 
species have multiple transcript isoforms associated with the Foxo1 gene. The region of the Foxo1 
gene cloned for probe synthesis is shown below in figure 4.3, depicted by arrow A. This is the second 
and final coding exon in the chick Foxo1 gene and shares many domains with the first coding exon. 
However, exon 2 contains some domains that are unique to it, such as the KIX binding domain and 
the transactivation domain. The transactivation domain is a binding domain that mediates the 
association of Foxo1 with the co-activator CBP/p300. The KIX binding domain binds to the CREB 
protein, and both domains simultaneously bind the KIX domain of CBP/p300 (Wang et al., 2012). It 
is feasible that this exon of the Foxo1 gene could be responsible for activity in only somites. Perhaps 
the function of Foxo1 in somites is related to the binding of these two proteins, which both play a role 
in regulating the transcription of genes.  
 
Figure 4.3: The protein domains found within the three exons of the gallus gallus Foxo1 gene. Arrow A depicts the second 
coding exon, which was the amplified and cloned region used to generate the Foxo1 probe. Adapted from ensembl. 
(https://www.ensembl.org/index.html 
4.7 Enhancer Control 
  It is well documented that several enhancers can interact with one gene, regulating different spatial 
and temporal activation of a gene (Hong et al., 2008, and see section 1.53 for more information). 
Enhancer construct 145 could activate endogenous Foxo1 expression in cells of an endothelial lineage 
only. This enhancer could contain binding sites for transcription factors that are found only in cells 
committed to an endothelial fate, resulting in enhancer and gene activation specific to these cells. 
Perhaps this enhancer communicates with a secondary promoter (as discussed above) to only produce 
a certain splice variant of the Foxo1 gene, with an as yet to be identified separate enhancer associated 
with the Foxo1 gene that activates expression in the somites.  
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4.8 Gene Synteny 
  The results of the gene synteny showed regions of synteny especially with other birds and lizards. 
These species are quite closely related, so the genomic region of Foxo1 has not been subjected to 
much evolutionary change within these species. Even in mammals, that are not as closely related to 
birds, blocks of synteny can still be identified, again meaning the genomic region of Foxo1 is 
conserved between species. The only species where this is not true are the mouse and rat, where the 3’ 
region to Foxo1 has no blocks of synteny. Potentially, this region of DNA was inserted at a new 
genomic location during evolution. There is also little gene synteny around the zebrafish Foxo1 gene, 
a species evolutionarily far from the chicken. However, this gene synteny analysis indicates that it is 
highly unlikely Foxo1 was mis-annotated in the chick genome. Therefore, from the gene synteny 
analysis, it is fairly certain that Foxo1 mRNA giving the strong expression pattern in the somites.  
  Another possibility is that the Foxo1 RNA probe is binding to mRNA transcripts of the structurally 
similar protein Foxo3. Foxo3 shows specific expression in the somites in X.tropicalis  (Zheng et al., 
2020). When sequenced, it was confirmed that Exon 2 of Foxo1 was cloned and amplified, and therefore 
the mRNA probe was Foxo-1 specific. However, the two mRNA sequences could be similar enough 
that this probe also bound to mRNA produced by Foxo3.  The percentage similarity between the Foxo1 
gene and the Foxo3 gene is only 45.5% (EMBOSS Water analysis). The actual region of Foxo1 cloned 
shows 51.7% identity with a region of the Foxo3 gene. The start of the Foxo1 probe region is very 
similar to a section of the Foxo3 cDNA, with only a few base pairs and missense regions (see 1.1 of 
appendix). It is possible that the Foxo3 mRNA produced by this region is similar enough to the RNA 
probe that it could bind and display signal. This possibility needs further investigation.  
4.9 Foxo1 Sequence Conservation and Phylogeny 
The sequence comparison of the Foxo1 gene between chick, human, mouse, and zebrafish indicated 
that most regions of the Foxo1 gene is conserved between (fig. 3.12). This suggests that Foxo1 is a 
functionally important gene, as there are few mutations within the gene between species, especially in 
the sequencing coding the protein domains. This suggests that any changes within the Foxo1 protein 
usually results in non-viable offspring. There are several other housekeeping genes that contain 
minimal mutations due to their importance in development, such as the HOX family of genes, which 
set the body plan of an organism in early embryonic development (Hrycaj and Wellik, 2016).  
The phylogenetic gene tree analyses represents the evolutionary history of the Foxo1 gene and its 
orthologue (daf-16). This tree was rooted to C.elegans, as a member of the more ancient clade 
Protostomia. The rest of this gene tree is as expected, and similar to the standard phylogeny of all 
species (Sanderson., 2008). There is a divergence event, separating the truncate P.mammillata as a 
sister phylum to the rest of the Foxo-1 proteins from the other vertebrae species. This is expected as 
the deuterostome and protostome species are less closely related, and even functionally important 
housekeeping genes would be genetically more separate between these two subphyla. The 
phylogenetic tree then groups together all the vertebrates as a clade, with the zebrafish as the most 
ancient member of this group. The tree follows the expected format for vertebrates; the amniotes 
(birds, mammals, and lizards) all share the same common ancestor. The only slight difference is the 
amphibian X.tropicalis is a placed in a sister group to the zebra fish, suggesting they share a common 
ancestor, when normally amphibians share a more ancient common ancestor with amniotes.   
Evolutionarily, Foxo1 is clearly an important gene, having orthologous (daf-16) in Turnicates and 
C.elegans, suggesting this gene is functionally ancient and is required throughout the animalia 
kingdom. This would suggest the Foxo1 protein is vital for a function that is required in less complex 
organisms, suggesting it has a fundamental role. This Foxo1 phylogenetic gene tree has a very similar 
format to the standard phylogenetic tree of life, with only the difference in the positioning of the frog 
species. This could be because Foxo1 is involved in the development of blood vessels, it may play a 
slightly different role in the amniotes. Fish and frogs have different circulatory systems than other 
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chordates (Heisler et al., 1999), and so during embryonic development, Foxo1 may contribute to the 
difference in the development of the vascular system. However, when looking at the sequence 
conservation, these differences are not major in any of the key domain regions of Foxo1, and the tree 
is probably diverging these species based on the non-protein domains of this gene, which does not 
have as important a role in the final protein produced.   
4.10 NKX2.5 Enhancer 
 During this project, an enhancer reporter construct associated with the Nkx2.5 gene displayed 
fluorescent signal in cells of the pharyngeal mesoderm and arches, as well as cardiac progenitor cells. 
Nkx2.5 is homeobox transcription factor that is expressed in early cardiac mesoderm and cardiac 
progenitor cells (Jamali et al., 2001) and is used as a marker for cells involved with heart formation. 
Conditional knockout of Nkx2.5 in mice display hearts malformations, and heterozygous knockouts 
show morphological and functional abnormalities in adult mice (Furtado et al., 2016). The potential 
enhancer associated with Nkx2.5 is found in the same cells as Nkx2.5, and it would be interesting to 
perform downstream analysis, including footprint analyses and CRISPR knockout experiments, to 
further validate and characterise this enhancer.    
4.11 Tendon development and the role of Scleraxis  
 Scleraxis is a gene described as being at the top of the differentiation pathway for tendons. It was 
therefore of interest to us to find an enhancer for this gene to further understand differentiation of the 
syndetome. Many previous studies have detected Scleraxis mRNA in the limb bud stages of chicken 
embryos using whole mount in-situ hybridisation techniques (Bret and Tabin, 2004, Perez et al., 2003, 
Asou et al., 2002) The earliest stage of Scleraxis detection was in HH16, from previous research in 
the Münsterberg lab. However, the analysed RNA-sequencing data showed high levels of scleraxis 
expression in HH14 embryos (see figure 3.7). This research was able to capture expression of 
scleraxis in a HH14 embryo during whole-mount in-situ hybridisations (fig.3.5). It was previously 
thought that Scleraxis was not induced in embryos until later stages, with uncommitted tendon 
progenitors remaining in the syndetome until scleraxis induces the tendon differentiation pathway. 
Our finding demonstrates that tendon progenitors are specified earlier than previously thought. This 
may have implications for the rest of the tendon specification programme, with genes like Mkx and 
Tendomoldin also being expressed earlier, potentially producing tendon specific cells. However, 
Scleraxis and Mkx protein in HH14 embryos could be waiting in tendon progenitor cells for the right 
developmental time point, where it along with other TFs binds to downstream target enhancers or 
promoter regions, and then activate expression of genes which continue the tendon differentiation 
programme. The tendon differentiation regulatory pathways need to be revised to understand why 
scleraxis transcripts are in the embryo as early as HH14 when it has previously been reported that 
tenocytes do not differentiate until tendon develops at HH20 (Edom-Vovard et al., 2002).  
  One approach to better characterise spatially and temporally tendon progenitors arise would be to 
find the enhancer controlling this gene. With this reporter construct, it would be possible to perform a 
time-lapse microscopy experiment using GFP as a visualiser for cells containing transcribed scleraxis 
protein. This project did attempt to find an enhancer region associated with Scleraxis, however only 
one putative enhancer construct was found from the ATAC-sequencing data set. The Münsterberg lab 
have mapped the ATAC-sequencing data to the UCSC 2015 chick genome browser, where Scleraxis 
is poorly annotated. When mapped to the chick genome, it did not align with any chromosome, and 
when viewed in UCSC chicken genome browser 2015 there is only a small flanking region around the 
gene body. However, in the updated chicken genome (2018 version) scleraxis fully maps to 
chromosome 2. If the ATAC-sequencing could be properly mapped to the genome for this region, 
more peaks may be visible in the flanking regions, making a more successful selection of a putative 
enhancer region possible for this gene.  
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4.12 TOMO-sequencing and Single Cell Sequencing expression patterns 
The TOMO-sequencing project utilised new sequencing approaches to identify novel genes found 
along the axis of the embryo. The genes Wnt5a, Nestin and HBM were known markers for dorsal 
mesoderm, neural crest cells and blood islands respectively, and both wnt5a and HBM in-situs show 
this expression pattern clearly. The genes TNFRSF14, ARIH1, AHNAK, LRIG3 and SZL were not 
associated with early embryonic development in the literature, with no expression data available in 
early embryos. Whilst the probes from TNFRSF14, AHNAK and SZL showed no specific activity, 
LRIG3 in-situs showed expression in the PSM and epithelial somites, and ARIM1 expression was 
restricted to the dorsal neural tube. The TOMO-sequencing identified high levels of these genes’ 
expression in the corresponding regions, proving that the TOMO-sequencing does act as a novel 
method to identify spatial patterns of gene expression.  
5. Future Work 
5.1 Improvements to culture and embryo transfection methods 
  The chick model was ideal for this study, as the Easy Culture method of ex-ovo manipulation is 
relatively cheap and easy. Although the chicken embryo is useful for studying early embryonic 
development, embryos rarely survive past HH14 when using easy culture methods. (Chapmen at al., 
2001). This issue could be tackled by implementing the modified Cornish pasty (MC) culture method, 
which enables ex-ovo growth of chicken embryos until HH18 (Nagai et al., 2011). If this could be 
implemented after injection and electroporation, it would potentially allow manipulated embryos to 
survive longer, thus allowing reporter construct fluorescence to be seen where previously embryos 
may not have survived long enough for activation of enhancer elements. This could be particularly 
important with putative enhancer elements associated with tendon development, as these genes are 
mainly expressed at the later stages of development.  
  Chicken embryos are highly sensitive when removed from their egg, and in more extreme weather 
conditions, with outside temperatures are either too cold or too hot, embryo quality seemed to decline. 
This is to be expected, however, removing embryos from their eggs would then further hamper their 
survivability. One way to maybe increase long-term survivability in the winter and summer months 
would be to implement the in-ovo electroporation technique (Scaal et al., 2004). Removal of an 
embryo from its environment using easy culture methods results in a drop in embryos survival, as this 
method cannot support the vascular development that surrounds the yolk and supplies the developing 
embryo with nutrients. However, in-ovo electroporation techniques allow the embryo to remain in the 
original environment, minimising the risk of the embryo dehydration when exposed to air upon 
removal for easy culture. This method also supplies the embryo with it all original supplements from 
the yolk, which would allow growth of an embryo to later stages, unlike easy culture methods where 
embryos are restricted for nutrient availability and space. If this method could be fully utilised in the 
lab, survival rates of embryos may increase, along with age of the surviving embryos. This could 
allow for identification of putative enhancer elements that are activated in later stages of development. 
A disadvantage is that there are no established protocols to electroporate gastrula stage embryos in 
ovo. Instead, somite-stage embryos from HH10 onwards would have to be injected and targeted, for 
example in the neural tube or epithelial somites. It may also be possible to use lipofection to deliver 
the enhancer-reporter construct into embryonic tissues in-ovo. 
5.2 Foxo1 Isoforms 
  Usually, the same cells will express both the enhancer reporter activity and mRNA expression. This 
is because the enhancer activates expression of the gene, which then produces mRNA, which is 
detected by whole mount in-situ hybridisations. This study reported the unusual discordance between 
the Foxo1 expression pattern in the somites and the putative enhancer construct in the blood islands 
and dorsal aorta. This could be due to probe specificity to one isoform, as described in section 5.6. To 
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test this, probes should be designed capturing the other exon of Foxo1, to determine if this region 
displays similarities to the Foxo1 putative enhancer expression patterns.  
5.3 Foxo1 Enhancers 
  As discussed above (5.6), the enhancer found close to the Foxo1 gene is responsible for activating 
expression in cells of an endothelial lineage. However, there could be another unknown enhancer 
acting upon the promoter region of Foxo1, which is responsible for activation in the somites. It would 
be worth revisiting the ATAC-sequencing dataset and identifying other regions of open chromatin that 
are near to Foxo1, with the aim of identifying a second enhancer that is involved with activating 
expression in the somites. However, during this project, six peaks were identified near the Foxo1 
gene, with only one showing reporter activity (Fig.3.6). There are other peaks that could be 
investigated further, however, it is possible that this specific enhancer is located further away, and 
works over many base pairs, by-passing other genes.   
5.4 Further Characterisation and ATAC-Foot printing analysis.  
  When transcription factors are bound to a region of DNA, it prevents the Tn5 enzyme binding and 
adding sequencing adaptors. This means these regions are not sequenced. These transcription factor 
bound regions leave a ‘footprint’ in the DNA; regions throughout the ATAC-sequencing peaks where 
the peak becomes a dip with two flanking shoulders. This has been exploited to identify candidate 
binding sites throughout the genome (Hesselberth et al., 2009) and has been advantageous in the 
systemic analysis of protein-DNA interactions, further characterising cis-regulatory elements (Sung et 
al., 2016). For this project, further characterisation of the Foxo1 enhancer using foot-printing methods 
would be interesting, especially to determine the presence of an endothelial-specific DNA-binding 
element that modulates the tissue specific activation of Foxo1 in endothelial cells. HINT-ATAC (Li et 
al., 2019) could be utilised in the lab to find differential TF footprints in regions of open chromatin as 
it significantly improves the recovery of footprints. 
5.5 Enhancer Discovery Pipeline  
  More work needs to be done to streamline this pipeline. The ATAC-sequencing data set, whilst 
useful in depicting regions of open chromatin that potentially have functional significance, cannot 
alone determine the presence of an enhancer. Using more of the data available from the ENCODE 
data base, such as methylation and histone acetylation marks, may help to identify putative enhancer 
regions. Marks such as H3K27Ac are present on active enhancers, and while there are no available 
genome wide datasets available for Histone marks in the chick, they are readily available in the 
human. This coupled with searching for conserved regions should enable more accurate selection of 
candidate enhancer peaks. Previous papers have performed ATAC-sequencing on samples removed 
from the neural crest. It would be interesting to compare the ATAC sequencing from neural crest 
samples with the ATAC-sequencing that the Münsterberg lab generated from somites. This might 
reveal differential peaks between the two samples, indicating regions that are open in somites and 
closed in neural crest. This might help identify open regions of chromatin involved specifically in 
somite development, therefore narrowing down the selection of possible peaks that are associated 
with enhancer regions.  
5.6 CRISPR Cas9 Experiments 
  The recent development of CRISPR-Cas9 (Clustered, regularly interspaced, short palindromic 
repeats (CRISPR) and the CRISPR- associated protein 9 (Cas9)) gives the opportunity for genome 
wide targeting (Cho et al., 2013). Until recently, its main use was targeted towards protein coding 
genes, but recently other studies have been successful in using CRISPR-Cas9 systems to identify 
enhancer elements in non-coding DNA (Korkmaz et al., 2016). This system has been utilised by the 
Sauka-Spengler lab (University of Oxford), who have recently developed a CRISPR-Cas9 ‘toolkit’ for 
in-vivo modulation of cis-regulatory elements (Williams et al.,2018). This study was the first reported 
method of epigenome engineering in a developing chick embryo and was able to silence whole 
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enhancer regions. This toolkit has been used recently in the lab (Mok et al., 2021), to functionally 
characterise the importance of the TCF15 and Meox1 cis-regulatory elements. There is potential that 
this approach to further characterise enhancers could be utilised in the lab.  
  Targeted deletions of transcription factor binding sites found using foot-printing data could be used 
to further characterise any enhancers discovered. Specifically targeting TF binding sites within a CRE 
with CRISPR-Cas9 would identify any key TFs that are required for activation of an enhancer 
element. This approach could be utilised here to further characterise the Foxo1 enhancer discovered, 
to determine if a specific TF is required for activation of this enhancer in cells of an endothelial 
lineage.  
  Previous studies have used a CRISPR-Cas9 genetic screen for enhancers within the human genome, 
by targeting TF binding sites in enhancer regions (Korkmaz et al., 2016). However, whilst this may 
work for some enhancer regions, and could be useful if incorporated, it is impossible to capture all 
enhancer regions with this method. This is because, as previously mentioned before, there is no 
underlying TF binding site that is mandatory for the function of all enhancer regions.  
  CRISPR-Cas9 could also be used here to determine the role of Foxo1 in rostral-caudal patterning. As 
this expression pattern has not been documented before, using CRISPR to knockout the Foxo1 gene 
would give an indication of its role. Whilst knockout experiments have already been performed for 
Foxo1 in mouse (Furuyama et al., 2004), the only aspect of development observed was the phenotypic 
result (abnormal angiogenesis). However, it would of interest to see if Foxo1 plays any role in the 
rostral-caudal patterning of somites. For this, Foxo1 expression could be silenced using CRISPR-cas9 
systems and then visualising the expression of genes known to be involved in the rostral-caudal 
patterning of somites, such as UNCX and TBX18, using real-time qPCR, or whole mount in-situ 
hybridisations. If expression of these genes differs to wild type expression, then Foxo1 potentially 
plays a role in this patterning system. If not, then Foxo1 could be acting downstream of these genes, 
and it would be interesting to see if any cis-regulatory regions for Foxo1 contained binding sites for 
genes known to be involved with rostral-caudal patterning, many of which are transcription factors.  
6. Concluding Remarks 
  Enhancers play a fundamental role in regulating the precise spatial and temporal gene expression 
patterns during embryonic development and differentiation. Many labs have focused their efforts on 
understanding how enhancers function, and in particular, how to identify which cis regulatory 
elements are involved in the control of a specific gene. There are many problems with attempting to 
identify specific enhancers, as there is no underlying sequence feature that discerns an enhancer from 
other non-coding regions of DNA. This project used ATAC-Sequencing data, which depicts regions 
of open chromatin to locate putative enhancer regions. The results discussed here show that even with 
the ATAC-sequencing tool, discovering functionally relevant CREs is difficult. The enhancer pipeline 
developed by the Münsterberg lab would benefit from both further bioinformatic and other functional 
data to find exact regions of open chromatin that correlate with an enhancer.  
  The continuation of this project will aim to characterise more cis-regulatory elements, and further 
our understanding of their involvement in gene regulatory networks involved with somite 
development throughout embryogenesis. It is critical that we understand how these non-coding 
regions of DNA work in biological systems, to understand diseases associated with them and to 
potentially develop therapies that target these regions.  
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8: Supplementary Information: 
 
 
SI Table 1: Primer pairs for amplification of cDNA of genes picked from the RNA-sequencing performed on somites.  
Gene Name Forward Primer Reverse Primer Successfully made into a 
probe? 
MKX GTCGTTAAAAACAATTTGTTTCCCTCC TTAAAACTGCTGGACTAATGGCA No 
Foxo1 GAAATGGTGACAGCCCTGGA CTCCCATATGGTCGACCTGC Yes 
SCX GGCCGTTACCTGTACCCC TAATTATACGAGCTGCTCAGGCT No 
TN-C TGTGACACACAGCAACCCTT CTTGCCCACAGCTTGTTTCC No 
UncX CGCCCACACCTCCTTGTATT GTCGGGGTTTACCTGCACTC No 
ALX-1 CTCTGTTTAACCAGCTCACACTAACA GATTGTTCTGAATCTGAGGATAGCTG No 
Pax9 GCAGACTTGGCAGTGTCCAT GTGAGTGTCCAGGAAGACCC Yes 
 
 
SI Table 2: Enhancer reporter constructs. A table showing all the putative enhancer I.D. numbers, along with their associated gene chromosomal location 
and size.  It records which candidate enhancer regions were successfully cloned into their reporter constructs, and for each of these if the injections and 
electroporation gave a positive result, and the number of times this was tested. It also shows if the reporter construct was electroporated alongside a control; 
pCIGcherry was injected and electroporated into each embryo at the same time as the fluorescent reporter construct. Enh88 was an enhancer region 
associated with MEOX1, that was injected into a separate embryo to the reporter construct, but under same conditions. 
Enhancer I.D Gene Chromosomal Location Size (bp) Successfully 
made into a 
construct? 






877 No N/A N/A N/A 
111 Mkx chr2:15,683,191-
15,683,507 
317 Yes No Enh 88 and 
pCIGcherry 
10 




1445 No N/A N/A N/A 
113 Tn-c chr17:3,126,923-3,127,556 634 No N/A N/A N/A 
114 Tn-c chr17:3,135,503-3,136,446 944 No N/A N/A N/A 





644 No N/A N/A N/A 
117 C-myc chr2:139,879,247-
139,880,935 
1689 No N/A N/A N/A 
118 ALX1 chr1:41,878,393-
41,879,398 
1006 Yes No Enh 88 15 
119 ALX1 chr1:41,845,375-
41,847,095 
1721 No N/A N/A N/A 
120 ALX1 chr1:41,898,180-
41,898,997 
818 No N/A N/A N/A 
121 UNCX chr14:2,403,710-2,404,244 664 No N/A N/A N/A 
122 UNCX chr14:2,409,861-2,411,010 1106 Yes No Enh 88 12 
123 UNCX chr14:2,392,241-2,392,829 589 No N/A N/A N/A 
124 KLHL31 chr3:88,499,135-
88,499,732 
687 Yes No pCIGCherry 12 
125 KLHL31 chr3:88,498,322-
88,498,659 
304 No N/A N/A N/A 
126 SCX chrUn_NT_468793v1:69-
333 
265 No N/A N/A N/A 
127 Pax1 chr3:3,487,269-3,487,720 452 No N/A N/A N/A 
128 Pax1 chr3:3,513,348-3,513,973 644 Yes No Enh 88 9 
129 Pax9 chr5:36,781,277-
36,782,013 
737 Yes No Enh 88 5 
130 MEOX2 chr2:28,088,450-
28,088,856407 
407 No N/A N/A N/A 
131 MEOX2 chr2:28,078,535-
28,079,316 
728 No N/A N/A N/A 
132 Foxo1 chr1:170,566,684-
170,567,320 
637 Yes No pCIGCherry  8 
133 Foxo1 chr1:170,723,431-
170,724,139 
709 Yes No pCIGCherry 7 




644 No N/A N/A N/A 
142 Foxo1 chr1:170,576,501-
170,577,708 
1208 Yes N/A N/A N/A 
143 Foxo1 chr1:170,601,084-
170,602,172 
1089 Yes No pCIGCherry 6 
144 Foxo1 chr1:170,619,863-
170,621,075 
1213 No N/A N/A N/A 
145 Foxo1 chr1:170,662,972-
170,663,695 
724 Yes Yes pCIGCherry 4 
146 Foxo1 chr1:170,698,791-
170,699,876 
1068 No N/A N/A N/A 
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SI Table 3: Successful PCR amplification primers. The forward and reverse primer pair for every fragment that was successfully amplified, inserted into a vector and made into a reporter 




Chromosomal location  Primer Pairs  
MKX chr2:15,683,191-15,683,507 Fw: GGGCCATCAAACTGAAGCG  
Rv: AATAATAACACTTCC 
TN-C chr17:3,139,373-3,140,841 Fw:AGCAGGTTAATAATAAAGCTACTGTACA 
Rv:TGAATTAGAACTCTAATCTTTACTTTCATCTCT 
ALX1 chr1:41,878,393-41,879,398 Fw:AATATGCTAAACTGGCAGTCCAGA  
Rv:TTGACTCTCCTTTTTTAAGCCTGGAA 
UNCX chr14:2,409,861-2,411,010 FW: CCCGTAGAGGCTGTGC 
Rv:CTAGTTTGGAGTTAAATGGCTCATAAAAGC 
KLHL31 chr3:88,499,135-88,499,732 Fw:ACATTGCCTTGCCAGCAGTA 
Rv:ATTCATGATAACACACTCTGGATTGTTTC 
SCX chrUn_NT_468793v1:69-333 Fw:GGGAGGGGGGAGTTGGGG 
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Rv: AGGGTGCCGTGGCTCAG 
PAX1 chr3:3,513,348-3,513,973 Fw:TTTGGGTTTGCCACACATCG 
Rv:ATACACAATCCAAATTAATGCAATGATCAACT 
PAX9 chr5:36,781,277-36,782,013 Fw:TCAGAGATGGTTAAAACCAAGGAGAA 
Rv: TGGAAATAAACCAATTTCCTTTATGGTGG 
FOXO1 chr1:170,566,684-170,567,320 Fw:AATTTGGCCTACTTACCAGAAGGG 
Rv:ATCTGCCTTGACAGTTTCTGGATAAAG 
FOXO1 chr1:170,723,431-170,724,139 Fw:GAGGAACAGTTCTTTGCAAAACTGC 
Rv:TAGTACTGGCAGATGACATATCAAAGGA 
 
SI Table 4: Primer sequences used to amplify regions of cDNA for generation of antisense RNA probes. This list encompasses the primers designed for the 
TOMO-Sequence project.  
Gene name Forward Primer Reverse Primer Successfully 
made into a 
probe? 
TNFRSF14  GCAGACTTGGCAGTGTCCAT GTGAGTGTCCAGGAAGACCC No 
ARIH1 ACCACATGGTCTGTCGGAAC GCTGCAACAAAACCCTTCGT Yes 
NES GGGGCGGAGGAAAGGAAATA CCCTGATTCTGGAAGAACCAAC No 
Wnt5a GCAGCACTGTGGACAACAAC CACCGTCTTGAACTGGTCGT Yes 
AHNAK CTGCTGACTGCAATCCCATTT AACTGGTGAGGATCCCTGTG Yes 
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HBM  CATCACACATTGCCACCAGC GCAGCAATGGTGTCTTTATTGA Yes 
SZL CAGCTGAAAACCAAGGGTTCG TGTGCGTGAAGAGTTCCTCC Yes 
LRIG3 GTCCTGACGCCTGGGAATTT AATCTGTGGGACAGGATGCC Yes 
 
SI Table 5: Primer sequences used to amplify regions of cDNA for generation of antisense probes for genes found to be of interest from the single cell RNA 
sequencing.  
Gene name Forward Primer Reverse Primer Successfully made into a 
probe? 
OLFML3 GGGAGTTCACGCTCTTCTCG GATGATCTGGTAGCCGTCGT Yes 
GPC4 CCACGAGATCAGCGAGTTCT AAGTCGTACCTGCTCTTGGC No 
PCP4 GATAGGAGGAGTGGTGAAGCAG GGACTGGGACCCCGCTTTTT No 
TBX22 GGATGTTCCCATCGGTCAGG AGACTTAGCGCTCTTCAGGC Yes 
FABP5 TTTGGATCCATTCGCAGCGG TACGGTCTTCTTGCCATCCC No 
NKX3-2 CTGACGCCTTTCTCCATCCA GCTGGTACTGTCTCTGGTCG No 
DCN TCTGGATTTGGGCCAGTGTG TGGTGTTGTAGCCAAGAGGG Yes 
EBF3 CCGTGCATAAAGGCCATCAG ACTGGTGCAAGATGGTGGAG Yes 
PRRX1 CGCCGGCCTGGACAATTTAC GTGGCCATGGCACTGTAAGG Yes 
KRT18 CAGCACCACTTTCTCCACCT GTTTGCGCAGAGCATCCAG No 
MSX2 AGCGAAGGAGGTTTTCTCCTC CTCTGTGAGGTTGAGGGAGC Yes 
CDX4 CCCCTACTCAGACTACATGGG TATGACCTGATGGATGTCAGCA Yes 
UNC45B AAGCTCTACGATGACCTGCG GAGGAACACCCTTGCGATGA Yes 
CHRNA1 GCACTGGGTTTACTACGCCT ATTCAATAAGGCGACCGGCA Yes 
NEBL AGGCCCTCACTGGATTTAGAC GAGTCAAACAACTTGCCGAG Yes 
SGCG CAACAACACCAGGCACTAGC CGACTCCAGCCTTAGCTGTT Yes 
MUSTN1 CAGTCACCGCCAGGAATAAC ACGTAGAAAGAACGCCCGTG Yes 
CTSK AAAGCAGTACAACGGCAAGG CACGTAGCCCTTATTGCCCC Yes 
LAMA2 CTACAGGCAGCCACTTTGGA ACGTGTTGAGCGAAGTCCAT Yes 
B3GNT4 GTTTGTGCTGAAGGGCGATG AGTGTTGTGAGCCTCCAGTG Yes 
CORO6 CAAAGTGTCACCGGCCTATT GGGGTGACTCCCGTTGA Yes 
RAPSN ATGCTGAAGTTCGCAGTGGT GACTCTCCACACATGCCACA Yes 
 
  





Figure S1: NPAS4 in-situ hybridisation and sectioning. A-D) In situ hybridisations to the NPAS4 RNA probe in A) HH4 
embryo, B) HH8 embryo and C)HH14. D) Close up of the staining in C. E) 20µM section of the epithelial somite from the 
embryo shown in C, at 20X magnification. F) Section of somite from embryo in C at 40X magnification.  
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Figure S2: An example of the positive controls used for the electroporation technique. A and C show the brightfield images 
of a HH10 embryo. B) The GFP reporter construct injected alone shows signal in cells that were targeted. C) The 
pCIGcherry reporter construct also shows which cells were successfully injected and electroporated and was frequently 




ATAC-Seq: Assay for Transposase Accessible Chromatin Sequencing 
BMP: Bone morphogenic protein 
ChIP-seq: Chromatin immunoprecipitation- sequencing 
CREB: Cyclic AMP-responsive element-binding 
CTCF: CCCTC-binding factor 
DNA: deoxyribonucleic acid 
EC: Early chick 
EMT: Epithelial to mesenchymal transition 
eQTL: Expression quantitative trait locus 
FAIRE-Seq: formaldehyde-assisted identification of regulatory elements- sequencing  
FGF: Fibroblast Growth Factor 
GFP: Green fluorescent protein 
HH: Hamburger-Hamilton stage  
MET: Mesenchymal to epithelial transition 
PAX: Paired box 
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PCR: Polymerase chain reaction 
PSM: Pre-somitic Mesoderm 
RA: Retinoic Acid 
RT: Room temperature 
Shh: Sonic Hedgehog 
SIX: Sine oculis-related homeobox  
TF: Transcription Factor 
TGF: Transforming growth factor 
TSS: Transcription start site 
WISH: Whole mount in-situ hybridisation 
 
For Images:  
HF: Head fold 
HT: Heat Tube  
LB: Limb Bud 
NT: Neural Tube 
PS: Primitive Streak 
So: Somite  
 
 
Figure S2: Pairwise sequence alignment of the Foxo1 sequence used for probe design (on top) and 
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10: Post-Script Comment 
After submission of the thesis and completion of the year in the lab, it was discovered that a mistake 
had been made in the lab regarding the labelling of probes. It transpired that the Foxo1 probe had been 
mislabelled and was a probe for the TBX22 gene. The produced in-situ images (Figures 3.1-3.4) were 
actually in-situ images for the gene TBX22. This means there is no need to further investigate the 
disparity between the in-situ images and the enhancer images. However, the finding of an enhancer 
associated with Foxo1 is still important for understanding the genetic regulation in the haematopoietic 
lineage, and a corresponding correct in-situ image for Foxo1 mRNA transcripts would show where 
Foxo1 is expressed in the chick embryo.  
TBX22 is a gene heavily involved in the rostral caudal patterning of somites in early development 
(Haneg et al., 2002). The in-situ images produced by this work also demonstrates this patterning (fig. 
3.1-3.4). In later development, TBX22 is crucial for the formation of the beak in chickens, and 
missense mutations in the coding region of the gene result in syndromes like clip left palate in humans 
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(Braybrook et al., 2002, Pauws et al., 2009 and Higashihori et al., 2010). However, it’s role in early 
development not been extensively studied in somitogenesis. As this in-situ has such strong specificity 
in early somites and pre-somitic mesoderm, it would be interesting to further study this gene and its 
genetic interactions at this earlier stage.  
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